Community Health Systems, Inc.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2008
Commission file number 001-15925
COMMUNITY HEALTH SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
|
13-3893191
(I.R.S. Employer
Identification Number) |
4000 Meridian Boulevard
Franklin, Tennessee
(Address of principal executive offices)
37067
(Zip Code)
615-465-7000
(Registrants telephone number)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days.
Yes þ No o
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer, or a smaller reporting company.
See the definitions of large
accelerated filer, accelerated filer
and smaller
reporting company in Rule 12b-2 of the
Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer þ |
|
Accelerated filer o |
|
Non-accelerated filer o
(Do not check if a smaller reporting company) |
|
Smaller reporting company
o |
Indicated by check mark whether the registrant is a shell company (as defined in Rule 126-2 of
the Exchange Act).
Yes o No þ
As of April 21, 2008, there were outstanding 96,231,791 shares of the Registrants Common
Stock, $.01 par value.
Community Health Systems, Inc.
Form 10-Q
For the Three Months Ended March 31, 2008
1
PART I FINANCIAL INFORMATION
Item 1. Financial Statements
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2008 |
|
|
2007 |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
164,353 |
|
|
$ |
132,874 |
|
Patient accounts receivable, net of allowance for doubtful accounts of $1,036,766 and
$1,033,516 at March 31, 2008, and December 31, 2007, respectively |
|
|
1,625,658 |
|
|
|
1,533,798 |
|
Supplies |
|
|
264,061 |
|
|
|
262,903 |
|
Prepaid income taxes |
|
|
110,160 |
|
|
|
99,417 |
|
Deferred income taxes |
|
|
113,741 |
|
|
|
113,741 |
|
Prepaid expenses and taxes |
|
|
83,852 |
|
|
|
70,339 |
|
Other current assets |
|
|
244,567 |
|
|
|
339,826 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
2,606,392 |
|
|
|
2,552,898 |
|
|
|
|
|
|
|
|
Property and equipment |
|
|
6,230,360 |
|
|
|
6,201,911 |
|
Less accumulated depreciation and amortization |
|
|
(791,963 |
) |
|
|
(689,337 |
) |
|
|
|
|
|
|
|
Property and equipment, net |
|
|
5,438,397 |
|
|
|
5,512,574 |
|
|
|
|
|
|
|
|
Goodwill |
|
|
4,375,293 |
|
|
|
4,247,714 |
|
|
|
|
|
|
|
|
Other assets, net |
|
|
912,267 |
|
|
|
1,180,457 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
13,332,349 |
|
|
$ |
13,493,643 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Current maturities of long-term debt |
|
$ |
19,476 |
|
|
$ |
20,710 |
|
Accounts payable |
|
|
461,437 |
|
|
|
492,693 |
|
Current income taxes payable |
|
|
|
|
|
|
|
|
Accrued interest |
|
|
90,442 |
|
|
|
153,832 |
|
Accrued liabilities |
|
|
731,271 |
|
|
|
780,700 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
1,302,626 |
|
|
|
1,447,935 |
|
|
|
|
|
|
|
|
Long-term debt |
|
|
8,886,355 |
|
|
|
9,077,367 |
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
407,947 |
|
|
|
407,947 |
|
|
|
|
|
|
|
|
Other long-term liabilities |
|
|
679,722 |
|
|
|
483,459 |
|
|
|
|
|
|
|
|
Minority interests in equity of consolidated subsidiaries |
|
|
384,129 |
|
|
|
366,131 |
|
|
|
|
|
|
|
|
Stockholders equity |
|
|
|
|
|
|
|
|
Preferred stock, $.01 par value per share, 100,000,000 shares authorized,
none issued |
|
|
|
|
|
|
|
|
Common stock, $.01 par value per share, 300,000,000 shares authorized;
97,195,340 shares issued and 96,219,791 shares outstanding
at March 31, 2008, and 96,611,085 shares issued and 95,635,536 shares
outstanding at December 31, 2007 |
|
|
972 |
|
|
|
966 |
|
Additional paid-in capital |
|
|
1,247,241 |
|
|
|
1,240,308 |
|
Treasury stock, at cost, 975,549 shares at March 31, 2008 and
December 31, 2007 |
|
|
(6,678 |
) |
|
|
(6,678 |
) |
Accumulated other comprehensive income |
|
|
(188,037 |
) |
|
|
(81,737 |
) |
Retained earnings |
|
|
618,072 |
|
|
|
557,945 |
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
1,671,570 |
|
|
|
1,710,804 |
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
13,332,349 |
|
|
$ |
13,493,643 |
|
|
|
|
|
|
|
|
See accompanying notes to the condensed consolidated financial statements.
2
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except share and per share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
Net operating revenues |
|
$ |
2,727,554 |
|
|
$ |
1,154,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses: |
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
1,087,770 |
|
|
|
462,765 |
|
Provision for bad debts |
|
|
297,080 |
|
|
|
128,054 |
|
Supplies |
|
|
386,409 |
|
|
|
134,294 |
|
Other operating expenses |
|
|
526,167 |
|
|
|
234,165 |
|
Rent |
|
|
59,857 |
|
|
|
24,756 |
|
Depreciation and amortization |
|
|
122,715 |
|
|
|
48,497 |
|
|
|
|
|
|
|
|
Total operating costs and expenses |
|
|
2,479,998 |
|
|
|
1,032,531 |
|
|
|
|
|
|
|
|
Income from operations |
|
|
247,556 |
|
|
|
121,747 |
|
Interest expense, net |
|
|
165,702 |
|
|
|
28,433 |
|
Loss from early extinguishment of debt |
|
|
1,328 |
|
|
|
|
|
Minority interest in earnings |
|
|
9,682 |
|
|
|
193 |
|
Equity in earnings of unconsolidated affiliates |
|
|
(12,884 |
) |
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
83,728 |
|
|
|
93,121 |
|
Provision for income taxes |
|
|
32,235 |
|
|
|
35,832 |
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
51,493 |
|
|
|
57,289 |
|
|
|
|
|
|
|
|
Discontinued operations, net of taxes: |
|
|
|
|
|
|
|
|
Loss from operations of hospitals sold and hospital held for sale |
|
|
(983 |
) |
|
|
(2,965 |
) |
Gain on sale of hospitals, net |
|
|
9,617 |
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) on discontinued operations |
|
|
8,634 |
|
|
|
(2,965 |
) |
|
|
|
|
|
|
|
Net income |
|
$ |
60,127 |
|
|
$ |
54,324 |
|
|
|
|
|
|
|
|
Income from continuing operations per common share: |
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.55 |
|
|
$ |
0.61 |
|
|
|
|
|
|
|
|
Diluted |
|
$ |
0.54 |
|
|
$ |
0.61 |
|
|
|
|
|
|
|
|
Net income per common share: |
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.64 |
|
|
$ |
0.58 |
|
|
|
|
|
|
|
|
Diluted |
|
$ |
0.63 |
|
|
$ |
0.58 |
|
|
|
|
|
|
|
|
Weighted-average number of shares outstanding: |
|
|
|
|
|
|
|
|
Basic |
|
|
94,107,532 |
|
|
|
93,402,545 |
|
|
|
|
|
|
|
|
Diluted |
|
|
95,006,721 |
|
|
|
94,365,292 |
|
|
|
|
|
|
|
|
See accompanying notes to the condensed consolidated financial statements.
3
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
Cash
flows from operating activities |
|
|
|
|
|
|
|
|
Net income |
|
$ |
60,127 |
|
|
$ |
54,324 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
122,478 |
|
|
|
51,270 |
|
Minority interest in earnings |
|
|
9,682 |
|
|
|
193 |
|
Stock-based compensation expense |
|
|
13,246 |
|
|
|
6,330 |
|
Gain on sale of hospitals, net |
|
|
(12,885 |
) |
|
|
|
|
Excess tax benefits relating to stock-based compensation |
|
|
947 |
|
|
|
(758 |
) |
Other non-cash expenses, net |
|
|
2,770 |
|
|
|
132 |
|
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures: |
|
|
|
|
|
|
|
|
Patient accounts receivable |
|
|
(100,057 |
) |
|
|
(33,322 |
) |
Supplies, prepaid expenses and other current assets |
|
|
(26,584 |
) |
|
|
(7,867 |
) |
Accounts payable, accrued liabilities and income taxes |
|
|
(81,965 |
) |
|
|
45,688 |
|
Other |
|
|
21,119 |
|
|
|
4,357 |
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
8,878 |
|
|
|
120,347 |
|
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Acquisitions of facilities and other related equipment |
|
|
(1,705 |
) |
|
|
(44,039 |
) |
Purchases of property and equipment |
|
|
(137,071 |
) |
|
|
(44,789 |
) |
Disposition of hospitals |
|
|
365,680 |
|
|
|
|
|
Proceeds from sale of property and equipment |
|
|
13,717 |
|
|
|
134 |
|
Increase in other assets |
|
|
(56,549 |
) |
|
|
(7,051 |
) |
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
|
|
184,072 |
|
|
|
(95,745 |
) |
|
|
|
|
|
|
|
Cash
flows from financing activities |
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
|
94 |
|
|
|
3,311 |
|
Excess tax benefits relating to stock-based compensation |
|
|
(947 |
) |
|
|
758 |
|
Deferred financing costs |
|
|
(2,232 |
) |
|
|
(14 |
) |
Proceeds from minority investors in joint ventures |
|
|
12,881 |
|
|
|
1,019 |
|
Redemption of minority investments in joint ventures |
|
|
|
|
|
|
(1,253 |
) |
Distributions to minority investors in joint ventures |
|
|
(7,524 |
) |
|
|
(1,079 |
) |
Borrowings under credit agreement |
|
|
25,000 |
|
|
|
|
|
Repayments of long-term indebtedness |
|
|
(188,743 |
) |
|
|
(5,032 |
) |
|
|
|
|
|
|
|
Net cash used in financing activities |
|
|
(161,471 |
) |
|
|
(2,290 |
) |
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
31,479 |
|
|
|
22,312 |
|
Cash and cash equivalents at beginning of period |
|
|
132,874 |
|
|
|
40,566 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
164,353 |
|
|
$ |
62,878 |
|
|
|
|
|
|
|
|
See accompanying notes to the condensed consolidated financial statements.
4
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1. BASIS OF PRESENTATION
The unaudited condensed consolidated financial statements of Community Health Systems, Inc. and its
subsidiaries (the Company) as of March 31, 2008 and for the three month periods ended March 31,
2008 and March 31, 2007, have been prepared in accordance with accounting principles generally
accepted in the United States of America (GAAP). In the opinion of management, such information
contains all adjustments, consisting only of normal recurring adjustments, necessary for a fair
presentation of the results for such periods. All intercompany transactions and balances have been
eliminated. The results of operations for the three months ended March 31, 2008, are not
necessarily indicative of the results to be expected for the full fiscal year ending December 31,
2008. Certain information and disclosures normally included in the notes to consolidated financial
statements have been condensed or omitted as permitted by the rules and regulations of the
Securities and Exchange Commission (SEC). The Company believes the disclosures are adequate to
make the information presented not misleading. The accompanying unaudited condensed consolidated
financial statements should be read in conjunction with the consolidated financial statements and
notes thereto for the year ended December 31, 2007, contained in the Companys Annual Report on
Form 10-K.
2. ACCOUNTING FOR STOCK-BASED COMPENSATION
Stock-based compensation awards are granted under the Community Health Systems, Inc. Amended and
Restated 2000 Stock Option and Award Plan (the 2000 Plan). The 2000 Plan allows for the grant of
incentive stock options intended to qualify under Section 422 of the Internal Revenue Code, as well
as stock options which do not so qualify, stock appreciation rights, restricted stock, performance
units and performance shares, phantom stock awards and share awards. Persons eligible to receive
grants under the 2000 Plan include the Companys directors, officers, employees and consultants.
To date, the options granted under the 2000 Plan have all been nonqualified stock options for tax
purposes. Generally, vesting of these granted options occurs in one third increments on each of
the first three anniversaries of the award date. Options granted prior to 2005 have a 10 year
contractual term, options granted in 2005 through 2007 have an 8 year contractual term and options
granted in 2008 have a 10 year contractual term. The exercise price of options granted to
employees under the 2000 Plan were equal to the fair value of the Companys common stock on the
option grant date. As of March 31, 2008, 3,525,142 shares of unissued common stock remain reserved
for future grants under the 2000 Plan.
The following table reflects the impact of total compensation expense related to stock-based equity
plans under the Statement of Financial Accounting Standards (SFAS) No. 123(R), on the reported
operating results for the respective periods (in thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
Effect on income from continuing
operations before income taxes |
|
$ |
(13,246 |
) |
|
$ |
(6,330 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect on net income |
|
$ |
(8,047 |
) |
|
$ |
(3,845 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect on net income per share-diluted |
|
$ |
(0.08 |
) |
|
$ |
(0.04 |
) |
|
|
|
|
|
|
|
SFAS No. 123(R) also requires the benefits of tax deductions in excess of the recognized tax
benefit on compensation expense to be reported as a financing cash flow, rather than as an
operating cash flow as required under Accounting Principles Board Opinion No. 25, Accounting for
Stock Issued to Employees and related interpretations. This requirement increased the Companys
net operating cash flows and decreased the Companys financing cash flows by $0.9 million for the
three months ended March 31, 2008. This requirement reduced the Companys net operating cash flows
and increased the Companys financing cash flows by $0.8 million for the three months ended March
31, 2007.
At March 31, 2008, $98.1 million of unrecognized stock-based compensation expense from all
outstanding unvested stock options and restricted stock is expected to be recognized over a
weighted-average period of 22 months.
The fair value of stock options was estimated using the Black Scholes option pricing model during
the three months ended March 31, 2008 and 2007, with the following assumptions:
5
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
2. ACCOUNTING FOR STOCK-BASED COMPENSATION (Continued)
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
March 31, |
|
|
2008 |
|
2007 |
Expected volatility |
|
|
24.1 |
% |
|
|
25.6 |
% |
Expected dividends |
|
|
0 |
|
|
|
0 |
|
Expected term |
|
4 years |
|
|
4 years |
|
Risk-free interest rate |
|
|
2.57 |
% |
|
|
4.48 |
% |
In determining expected return, the Company examined concentrations of option holdings, historical
patterns of option exercises and forfeitures, as well as forward looking factors, in an effort to
determine if there were any discernable employee populations. From this analysis, the Company
identified two employee populations, one consisting primarily of certain senior executives and the
other consisting of all other recipients.
The expected volatility rate was estimated based on historical volatility. In determining expected
volatility, the Company also reviewed the market-based implied volatility of actively traded
options of its common stock and determined that historical volatility did not differ significantly
from the implied volatility.
The expected life computation is based on historical exercise and cancellation patterns and forward
looking factors, where present, for each population identified. The risk-free interest rate is
based on the U.S. Treasury yield curve in effect at the time of the grant. The pre-vesting
forfeiture rate is based on historical rates and forward looking factors for each population
identified. The Company adjusts the estimated forfeiture rate to its actual experience. Options
outstanding and exercisable under the 2000 Plan as of March 31, 2008, and changes
during the three months then ended were as follows (in thousands, except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
average |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
remaining |
|
|
Aggregate |
|
|
|
|
|
|
|
average |
|
|
contractual |
|
|
intrinsic |
|
|
|
|
|
|
|
exercise |
|
|
term |
|
|
value as of |
|
|
|
Shares |
|
|
price |
|
|
(in years) |
|
|
March 31, 2008 |
|
Outstanding at December 31, 2007 |
|
|
8,439,015 |
|
|
$ |
30.90 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
996,500 |
|
|
|
32.28 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(11,666 |
) |
|
|
23.26 |
|
|
|
|
|
|
|
|
|
Forfeited and cancelled |
|
|
(172,600 |
) |
|
|
35.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2008 |
|
|
9,251,249 |
|
|
$ |
30.98 |
|
|
6.4 years |
|
$ |
43,418 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at March 31, 2008 |
|
|
4,805,509 |
|
|
$ |
25.64 |
|
|
5.5 years |
|
$ |
41,971 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The weighted-average grant date fair value of stock options granted during the three months ended
March 31, 2008, was $7.55. The aggregate intrinsic value (the number of in-the-money stock options
multiplied by the difference between the Companys closing stock price on the last trading day of
the reporting period ($33.57) and the exercise price of the respective stock options) in the table
above represents the amount that would have been received by the option holders had all option
holders exercised their options on March 31, 2008. This amount changes based on the market value
of the Companys common stock. The aggregate intrinsic value of options exercised during the three
months ended March 31, 2008 was $0.1 million and the aggregate intrinsic value of options exercised
during the three months ended March 31, 2007 was $1.4 million. The aggregate intrinsic value of
options vested and expected to vest approximates that of the outstanding options.
The Company has also awarded restricted stock under the 2000 Plan to its directors and various
subsidiaries employees. The restrictions on these shares generally lapse in one-third increments
on each of the first three anniversaries of the award date, except for restricted stock granted on
July 25, 2007, which restrictions generally lapse equally on the first two anniversaries of the
award date. Certain of the restricted stock awards granted to the Companys senior executives also
contain a performance objective that must be met in addition to the vesting requirements. If the
performance objective is not attained the awards will be forfeited in their entirety. Once the
performance objective has been attained, restrictions will lapse in one-third increments on
6
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
2. ACCOUNTING FOR STOCK-BASED COMPENSATION (Continued)
each of the first three anniversaries of the award date with the exception of the July 25, 2007
restricted stock awards, which have no additional time vesting restrictions. Notwithstanding the
above mentioned performance objectives and vesting requirements, the restrictions will lapse
earlier in the event of death, disability, termination of employment of the holder of the
restricted stock by employer for any reason other than for cause or in the event of change in
control of the Company. Restricted stock awards subject to performance standards are not
considered outstanding for purposes of determining earnings per share until the performance
objectives have been satisfied.
Restricted stock outstanding under the 2000 Plan as of March 31, 2008, and changes during the three
months then ended are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
average |
|
|
|
|
|
|
fair |
|
|
Shares |
|
value |
Unvested at December 31, 2007 |
|
|
1,956,543 |
|
|
$ |
38.04 |
|
Granted |
|
|
748,500 |
|
|
|
32.38 |
|
Vested |
|
|
(592,505 |
) |
|
|
36.09 |
|
Forfeited |
|
|
(3,000 |
) |
|
|
37.20 |
|
|
|
|
|
|
|
|
|
|
Unvested at March 31, 2008 |
|
|
2,109,538 |
|
|
|
36.58 |
|
|
|
|
|
|
|
|
|
|
As of March 31, 2008, there was $64.8 million of unrecognized stock-based compensation expense
related to unvested restricted stock expected to be recognized over a weighted-average period of 21
months.
Under the Directors Fee Deferral Plan, the Companys outside directors may elect to receive share
equivalent units in lieu of cash for their directors fee. Share equivalent units are calculated
by dividing the deferred directors fees by the closing market price of the Companys common stock
on the last trading day of the reporting period. These units are held in the plan until the
director electing to receive the share equivalent units retires or otherwise terminates his/her
directorship with the Company. Share equivalent units are converted to shares of common stock of
the Company at the time of distribution. The following table represents the amount of directors
fees which were deferred and the equivalent units into which they converted for each of the
respective periods:
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
Directors fees earned
and deferred into plan |
|
$ |
40,875 |
|
|
$ |
35,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equivalent units |
|
|
1,217.605 |
|
|
|
1,017.731 |
|
|
|
|
|
|
|
|
At March 31, 2008, there are a total of 14,626.137 units deferred in the plan with an aggregate
fair value of $0.5 million, based on the closing market price of the Companys common stock on the
last trading day of the reporting period of $33.57.
3. COST OF REVENUE
The majority of the Companys operating costs and expenses are cost of revenue items. Operating
costs that could be classified as general and administrative by the Company would include the
Companys corporate office costs at the Companys Franklin, Tennessee office, which were $38.1
million and $23.1 million for the three month periods ended March 31, 2008 and 2007, respectively.
Included in these amounts is stock-based compensation expense of $13.2 million and $6.3 million for
the three month periods ended March 31, 2008 and 2007, respectively.
4. USE OF ESTIMATES
The preparation of financial statements in conformity with GAAP requires management to make
estimates and assumptions that affect the amounts reported in the condensed consolidated financial
statements. Actual results could differ from these estimates.
7
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
5. ACQUISITIONS AND DIVESTITURES
Triad Acquisition
On July 25, 2007, the Company completed its acquisition of Triad. Triad owned and operated 50
hospitals in non-urban and middle market communities in 17 states, as well as the Republic of
Ireland. Immediately following the acquisition, on a combined basis, the Company owned and
operated 128 hospitals in 28 states, as well as the Republic of Ireland. As of December 31, 2007,
two hospitals acquired from Triad had been sold and six hospitals acquired from Triad were
classified as held for sale. During the three months ended March 31, 2008, the Company completed
the sale of five of the six former Triad hospitals held for sale at December 31, 2007. The Company also
provides management and consulting services on a contract basis to independent hospitals, through
its subsidiary, Quorum Health Resources, LLC, which was acquired as part of the acquisition of
Triad. The Company acquired Triad for approximately $6.836 billion, including the assumption of
$1.686 billion of existing indebtedness.
In connection with the consummation of the acquisition of Triad, the Company obtained $7.215
billion of senior secured financing under a new credit facility (the New Credit Facility) and its
wholly-owned subsidiary CHS/Community Health Systems, Inc. (CHS) issued $3.021
billion aggregate principal amount of 8.875% senior notes due 2015 (the Notes). The Company used
the net proceeds of $3.000 billion from the Notes offering and the net proceeds of $6.065 billion
of term loans under the New Credit Facility to acquire the outstanding shares of Triad, to
refinance certain of Triads indebtedness and the Companys indebtedness, to complete certain
related transactions, to pay certain costs and expenses of the transactions and for general
corporate uses. This New Credit Facility also provides an additional $750 million revolving credit
facility and a $300 million delayed draw term loan facility for future acquisitions, working
capital and general corporate purposes. The delayed draw term loan was reduced from $400 million
to $300 million at the request of the Company in the fourth quarter of 2007.
The total cost of the Triad acquisition has been allocated to the assets acquired and liabilities
assumed based upon their respective preliminary estimated fair values in accordance with SFAS No.
141. The purchase price represented a premium over the fair value of the net tangible and
identifiable intangible assets acquired for reasons such as:
|
|
strategically, Triad had operations in five states in which the Company previously had no
operations; |
|
|
|
the combined company has smaller concentrations of credit risk through greater geographic
diversification; |
|
|
|
many support functions will be centralized; and |
|
|
|
duplicate corporate functions will be eliminated. |
The allocation process requires the analysis of acquired fixed assets, contracts, contractual
commitments, and legal contingencies to identify and record the fair value of all assets acquired
and liabilities assumed. The values of certain assets and liabilities are based on preliminary
valuations and are subject to adjustment as additional information is obtained. Such additional
information includes, but is not limited to: valuations of property and equipment, valuation of
equity investments and intangible assets, valuation of contractual commitments, finalization of
involuntary termination of employees, and review of open cost report settlement periods. The
Company is also negotiating the termination of certain assumed contracts it deems unfavorable, such
as various physician and service contracts. Under GAAP, the Company has up to twelve months from
the closing of the acquisition to complete its valuations and complete contract terminations in
order for these terminations to be considered in the allocation process. The Company expects to
complete the allocation of the total cost of the Triad acquisition in the second quarter of 2008.
Material adjustments to goodwill may result upon the completion of these matters.
Other Acquisitions
Effective April 1, 2007, the Company completed its acquisition of Lincoln General Hospital (157
licensed beds), located in Ruston, Louisiana. The total consideration for this hospital was
approximately $49.4 million, of which $44.7 million was paid in cash and $4.7 million was assumed
in liabilities. On May 1, 2007, the Company completed its acquisition of Porter Health (301
licensed beds), located in Valparaiso, Indiana, with a satellite campus in Portage, Indiana and
outpatient medical campuses located in Chesterton, Demotte, and Hebron, Indiana. As part of this
acquisition, the Company has agreed to construct a 225-bed replacement facility for the Valparaiso
hospital no later than April 2011. The total consideration for Porter Health was approximately
$113.4 million, of which $88.9 million was paid in cash and $24.5 million was assumed in
liabilities. The Company has estimated its purchase price allocation relating to these acquisitions
resulting in approximately $8.1 million of goodwill being recorded. The allocation of Porter
Health is preliminary pending, among other things, finalization of valuation of tangible and
intangible assets. These acquisition transactions were accounted for using the purchase method of
accounting. The
8
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
5. ACQUISITIONS AND DIVESTITURES (Continued)
allocation of the purchase price has been determined by the Company based upon available
information and is subject to settling amounts related to purchased working capital and in some
instances final appraisals. Adjustments to the purchase price allocation are not expected to be
material.
Discontinued Operations
Effective March 1, 2008, the Company sold Woodland Medical Center (100 licensed beds) located in
Cullman, Alabama; Parkway Medical Center (108 licensed beds) located in Decatur, Alabama; Hartselle
Medical Center (150 licensed beds) located in Hartselle, Alabama; Jacksonville Medical Center (89
licensed beds) located in Jacksonville, Alabama; National Park Medical Center (166 licensed beds)
located in Hot Springs, Arkansas; St. Marys Regional Medical Center (170 licensed beds) located in
Russellville, Arkansas; Mineral Area Regional Medical Center (135 licensed beds) located in
Farmington, Missouri; Willamette Valley Medical Center (80 licensed beds) located in McMinnville,
Oregon; and White County Community Hospital (60 licensed beds) located in Sparta, Tennessee, to
Capella Healthcare, Inc., headquartered in Franklin, Tennessee. The proceeds from this sale were
$315 million in cash.
Effective February 21, 2008, the Company sold THI Ireland Holdings Limited, a private limited
company incorporated in the Republic of Ireland, which leased and managed the operations of Beacon
Medical Center (122 licensed beds) located in Dublin, Ireland, to Beacon Medical Group Limited,
headquartered in Dublin, Ireland. The proceeds from this sale were $1.5 million in cash.
Effective February 1, 2008, the Company sold Russell County Medical Center (78 licensed beds)
located in Lebanon, Virginia to Mountain States Health Alliance, headquartered in Johnson City,
Tennessee. The proceeds from this sale were $48.6 million in cash.
Effective November 30, 2007, the Company sold Barberton Citizens Hospital (312 licensed beds)
located in Barberton, Ohio to Summa Health System of Akron, Ohio. The proceeds from this sale were
$53.8 million in cash.
Effective October 31, 2007, the Company sold its 60% membership interest in Northeast Arkansas
Medical Center, a 104 bed facility in Jonesboro, Arkansas to Baptist Memorial Health Care
(Baptist), headquartered in Memphis, Tennessee for $16.8 million. In connection with this
transaction, the Company also sold real estate and other assets to a subsidiary of Baptist for
$26.2 million in cash.
Effective September 1, 2007, the Company sold its partnership interest in River West L.P., which
owned and operated River West Medical Center (an 80 bed facility) located in Plaquemine, Louisiana
to an affiliate of Shiloh Health Services, Inc. of Lubbock, Texas. The proceeds from this sale were
$0.3 million in cash.
As of March 31, 2008, the Company had one hospital classified as held for sale.
In connection with the above actions and in accordance with SFAS No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets, the Company has classified the results of operations
of the above mentioned hospitals as discontinued operations in the accompanying condensed
consolidated statements of income.
Net operating revenues and income (loss) on discontinued operations for the respective periods are
as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
Net operating revenues |
|
$ |
106,633 |
|
|
$ |
49,719 |
|
|
|
|
|
|
|
|
Loss from operations of hospitals sold or held
for sale before income taxes |
|
|
(789 |
) |
|
|
(4,789 |
) |
Gain on sale of hospitals, net |
|
|
17,724 |
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations before taxes |
|
|
16,935 |
|
|
|
(4,789 |
) |
Income tax (expense) benefit |
|
|
(8,301 |
) |
|
|
1,824 |
|
|
|
|
|
|
|
|
Income (loss) on discontinued operations, net of tax |
|
$ |
8,634 |
|
|
$ |
(2,965 |
) |
|
|
|
|
|
|
|
9
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
5. ACQUISITIONS AND DIVESTITURES (Continued)
The computation of income from discontinued operations, before taxes, for the three months ended
March 31, 2008 includes the net write-off of $96.3 million of tangible assets and $32.5 million of
goodwill (including $21.3 million of goodwill included in non-current assets held for sale at
December 31, 2007) at the hospitals sold during the three months ended March 31, 2008.
Interest expense was allocated to discontinued operations based on estimated sale proceeds
available for debt repayment.
The assets and liabilities of one hospital held for sale as of March 31, 2008 are included in the
accompanying condensed consolidated balance sheet as follows: current assets of $19.7 million,
included in other current assets; net property and equipment of $53.3 million and other long-term
assets of $0.1 million, included in other assets; and current liabilities of $23.5 million,
included in other accrued liabilities.
The assets and liabilities of the hospitals held for sale as of December 31, 2007 are included in
the accompanying condensed consolidated balance sheet as follows: current assets of $118.9 million,
included in other current assets; net property and equipment of $331.1 million and other long-term
assets of $86.0 million, included in other assets; and current liabilities of $67.6 million,
included in accrued liabilities.
6. INCOME TAXES
The Company adopted the provisions of FASB Interpretation No. 48, Accounting for Uncertainty in
Income Taxes (FIN 48), on January 1, 2007. The total amount of unrecognized benefit that would
affect the effective tax rate, if recognized, is approximately $5.9 million as of March 31, 2008.
It is the Companys policy to recognize interest and penalties accrued related to unrecognized
benefits in its condensed consolidated statements of income as income tax expense. During the three months ended March
31, 2008, the Company recorded approximately $0.2 million in interest and penalties related to
prior state income tax returns through its income tax provision from continuing operations and
which are included in its FIN 48 liability at March 31, 2008. A total of approximately $1.9 million
of interest and penalties is included in the amount of FIN 48 liability at March 31, 2008.
The Companys unrecognized tax benefits consist primarily of state exposure items. The Company
believes that it is reasonably possible that approximately $1.2 million of its current unrecognized
tax benefit may decrease within the next twelve months as a result of a lapse of the statute of
limitations and settlements with taxing authorities.
The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction
and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S.
federal or state income tax examinations for years prior to 2003.
The IRS
has concluded an examination of the federal income tax returns of
Triad for the short taxable years ended April 27, 2001,
June 30, 2001 and December 31, 2001, and the taxable years
ended December 31, 2002 and 2003. The Company has received a
closing letter from the IRS with respect to the examination for those
tax years. The settlement was not material to the Companys
consolidated results of operations or consolidated financial position.
Cash paid for income taxes, net of refunds received, resulted in a net cash refund of $2.8 million
for the three months ended March 31, 2008 and net cash paid of $13.2 million during the three
months ended March 31, 2007.
7. GOODWILL AND OTHER INTANGIBLE ASSETS
The changes in the carrying amount of goodwill for the three months ended March 31, 2008, are as
follows (in thousands):
|
|
|
|
|
Balance as of December 31, 2007 |
|
$ |
4,247,714 |
|
Goodwill acquired as part of acquisitions during 2008 |
|
|
114 |
|
Consideration adjustments and finalization of purchase price
allocations for acquisitions completed prior to 2008 |
|
|
138,626 |
|
Goodwill written-off as part of disposals |
|
|
(11,161 |
) |
|
|
|
|
Balance as of March 31, 2008 |
|
$ |
4,375,293 |
|
|
|
|
|
Goodwill related to the former Triad hospitals of $3.039 billion has not been allocated to the
reporting unit level as of March 31, 2008 because the final purchase price allocation has not been
completed (see Note 5).
The Company completed its most recent annual goodwill impairment test as required by SFAS No. 142,
Goodwill and Other Intangible Assets, during 2007, using a measurement date of September 30,
2007. Based on the results of the impairment test, the Company was not required to recognize an
impairment of goodwill in 2007.
10
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
7. GOODWILL AND OTHER INTANGIBLE ASSETS (Continued)
The gross carrying amount of the Companys other intangible assets was $202.3 million at March 31,
2008 and $194.6 million at December 31, 2007, and the net carrying amount was $187.1 million at
March 31, 2008 and $181.0 million at December 31, 2007. Other intangible assets are included in
other assets, net on the Companys condensed consolidated balance sheets.
The weighted-average amortization period for the intangible assets subject to amortization is
approximately eight years. There are no expected residual values related to these intangible
assets. Amortization expense on these intangible assets during the three months ended March 31,
2008 and March 31, 2007 was $2.4 million and $0.5 million, respectively. Amortization expense on
intangible assets is estimated to be $11.6 million for the remainder of 2008, $14.0 million in
2009, $13.0 million in 2010, $11.9 million in 2011, $9.7 million in 2012, and $0.3 million in 2013
and thereafter.
8. EARNINGS PER SHARE
The following table sets forth the components of the numerator and denominator for the computation
of basic and diluted income from continuing operations per share (in thousands, except share data):
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
|
|
2008 |
|
|
2007 |
|
Numerator: |
|
|
|
|
|
|
|
|
Numerator for basic earnings per share - |
|
|
|
|
|
|
|
|
Income from continuing operations available to
common stockholders basic |
|
$ |
51,493 |
|
|
$ |
57,289 |
|
|
|
|
|
|
|
|
Numerator for diluted earnings per share - |
|
|
|
|
|
|
|
|
Income from continuing operations available
to common stockholders diluted |
|
$ |
51,493 |
|
|
$ |
57,289 |
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
Weighted-average number of shares outstanding basic |
|
|
94,107,532 |
|
|
|
93,402,545 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
Non-employee director options |
|
|
|
|
|
|
11,826 |
|
Restricted stock awards |
|
|
77,299 |
|
|
|
36,235 |
|
Employee options |
|
|
821,890 |
|
|
|
914,686 |
|
|
|
|
|
|
|
|
Weighted-average number of shares outstanding diluted |
|
|
95,006,721 |
|
|
|
94,365,292 |
|
|
|
|
|
|
|
|
Dilutive securities outstanding not included in the
computation of earning per share because their effect is
antidilutive: |
|
|
|
|
|
|
|
|
Employee options |
|
|
4,361,131 |
|
|
|
1,926,567 |
|
9. STOCKHOLDERS EQUITY
Authorized capital shares of the Company include 400,000,000 shares of capital stock consisting of
300,000,000 shares of common stock and 100,000,000 shares of preferred stock. Each of the
aforementioned classes of capital stock has a par value of $.01 per share. Shares of preferred
stock, none of which are outstanding as of March 31, 2008 may be issued in one or more series
having such rights, preferences and other provisions as determined by the Board of Directors
without approval by the holders of common stock.
On January 14, 2006, the Company commenced an open market repurchase program for up to 5,000,000
shares of the Companys common stock, not to exceed $200 million in repurchases. Under this
program, the Company repurchased the entire 5,000,000 shares at a weighted average price of $35.23.
This program concluded on November 8, 2006 when the maximum number of shares had been repurchased.
This repurchase plan followed a prior repurchase plan for up to 5,000,000 shares which concluded on
January 13, 2006. The Company repurchased 3,029,700 shares at a weighted average price of $31.20
per share under this program. On December 13, 2006, the Company commenced another open market
repurchase program for up to 5,000,000 shares of the Companys common stock, not to exceed $200
million in repurchases. This program will conclude at the earlier of three years or when the
maximum number of shares has been repurchased. As of March 31, 2008, the Company has not
repurchased any shares under this program.
11
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
10. COMPREHENSIVE INCOME
The following table presents the components of comprehensive income, net of related taxes. The net
change in fair value of interest rate swap agreements is a function of the spread between the fixed
interest rate of each swap and the underlying variable interest rate under the Companys New Credit
Facility, the change in fair value of available for sale securities is the unrealized gain (losses)
on the related investments and the amortization of unrecognized pension cost components is the
amortization of prior service costs and credits and actuarial gains and losses (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
Net income |
|
$ |
60,127 |
|
|
$ |
54,324 |
|
Net change in fair value of interest rate swaps |
|
|
(104,554 |
) |
|
|
(3,870 |
) |
Net change in fair value of available for sale securities |
|
|
(753 |
) |
|
|
(213 |
) |
Amortization of unrecognized pension components |
|
|
(993 |
) |
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
$ |
(46,173 |
) |
|
$ |
50,241 |
|
|
|
|
|
|
|
|
The net change in fair value of the interest rate swaps, the net change in fair value of available
for sale securities and amortization of unrecognized pension cost components are included in
stockholders equity on the accompanying condensed consolidated balance sheets.
11. EQUITY INVESTMENTS
The Company owns equity interests of 27.5% in four hospitals in Las Vegas, Nevada, and 26.1% in one
hospital in Las Vegas, Nevada in which Universal Health Systems, Inc. owns the majority interest;
an equity interest of 38.0% in a hospital in Macon, Georgia in which HCA Inc. owns the majority
interest; and an equity interest of 50.0% in a hospital in El Dorado, Arkansas in which the SHARE
Foundation, a not-for-profit foundation, owns the remaining 50.0%. These equity investments were
acquired as part of the acquisition of Triad. The Company uses the equity method of accounting for
its investments in these entities. The balance of the Companys investment in unconsolidated
affiliates is $276.5 million and $213.3 million at March 31, 2008 and December 31, 2007,
respectively, and is included in other assets in the accompanying condensed consolidated balance
sheet. Included in the Companys results of operations for the quarter ended March 31, 2008, is
$12.9 million representing the Companys equity in pre-tax earnings from investments in
unconsolidated affiliates.
Summarized combined financial information for the three months ended March 31, 2008, for the
unconsolidated entities in which the Company owns an equity interest is as follows (in thousands):
|
|
|
|
|
|
|
For the three months ended |
|
|
March 31, 2008 |
Revenues |
|
$ |
363,667 |
|
Net income |
|
|
50,955 |
|
12. LONG-TERM DEBT
Terminated Credit Facility and Notes
On
August 19, 2004, CHS entered into a $1.625 billion senior secured credit facility with a
consortium of lenders which was subsequently amended on December 16, 2004, July 8, 2005 and
December 13, 2006 (the Terminated Credit Facility). The purpose of the Terminated Credit Facility
was to refinance and replace the Companys previous credit agreement, repay specified other
indebtedness, and fund general corporate purposes, including amending the credit facility to permit
declaration and payment of cash dividends, to repurchase shares or make other distributions,
subject to certain restrictions. The Terminated Credit Facility consisted of a $1.2 billion term
loan that was due to mature in 2011 and a $425 million revolving credit facility that was due to
mature in 2009. The First Incremental Facility Amendment, dated as of December 13, 2006, increased
the Companys term loans by $400 million (the Incremental Term Loan Facility) and also gave the
Company the ability to add up to $400 million of additional term loans. The full amount of the
Incremental Term Loan Facility was funded on December 13, 2006, and the proceeds were used to repay
the full outstanding amount (approximately $326 million) of the revolving credit facility under the
Terminated Credit Agreement and the balance was available to be used for general corporate
purposes. The Company was able to elect from time to time an interest rate per annum for the
borrowings under the term loan, including the incremental term loan,
12
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
12. LONG-TERM DEBT (Continued)
and revolving credit facility equal to (a) an alternate base rate, which would have been equal to
the greatest of (i) the Prime Rate (as defined) in effect and (ii) the Federal Funds Effective Rate
(as defined), plus 50 basis points, plus (1) 75 basis points for the term loan and (2) the
Applicable Margin (as defined) for revolving credit loans or (b) the Eurodollar Rate (as defined)
plus (1) 175 basis points for the term loan and (2) the Applicable Margin for Eurodollar revolving
credit loans. The Company also paid a commitment fee for the daily average unused commitments under
the revolving credit facility. The commitment fee was based on a pricing grid depending on the
Applicable Margin for Eurodollar revolving credit loans and ranged from 0.250% to 0.500%. The
commitment fee was payable quarterly in arrears and on the revolving credit termination date with
respect to the available revolving credit commitments. In addition, the Company paid fees for each
letter of credit issued under the credit facility.
On
December 16, 2004, the Company issued $300 million 6-1/2% senior subordinated notes due 2012. On
April 8, 2005, the Company exchanged these notes for notes having substantially the same terms as
the outstanding notes, except the exchanged notes were registered under the Securities Act of 1933,
as amended (the 1933 Act). The debt was repaid in 2007.
New Credit Facility and Notes
On July 25, 2007, the New Credit Facility was entered into with a syndicate of financial
institutions led by Credit Suisse, as administrative agent and collateral agent. The New Credit
Facility consists of a $6.065 billion funded term loan facility with a maturity of seven years, a
$400 million delayed draw term loan facility with a maturity of seven years and a $750 million
revolving credit facility with a maturity of six years. As of December 31, 2007, the $400 million
delayed draw term loan had been reduced to $300 million at the request of the Company. The
revolving credit facility also includes a subfacility for letters of credit and a swingline
subfacility. As previously disclosed, in connection with the consummation of the acquisition of
Triad, the Company used a portion of the net proceeds from its New Credit Facility and the Notes
offering to repay its outstanding debt under the Terminated Credit Facility, the 6-1/2% Notes and
certain of Triads existing indebtedness. During the third quarter of 2007, the Company recorded a
pre-tax write-off of approximately $13.9 million in deferred loan costs relative to the early
extinguishment of the debt under the Terminated Credit Facility and incurred tender and
solicitation fees of approximately $13.4 million on the early repayment of the Companys $300
million aggregate principal amount of 6-1/2% Senior Subordinated Notes due 2012 through a cash
tender offer and consent solicitation.
The New Credit Facility requires quarterly amortization payments of each term
loan facility equal to 0.25% of the outstanding amount of the term loans, if any, with the
outstanding principal balance payable on July 25, 2014.
The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of
certain asset sales and dispositions by the Company and its subsidiaries, subject to certain
exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt
obligations or receivables based financing by the Company and its subsidiaries, subject to certain
exceptions, and (3) 50%, subject to reduction to a lower percentage based on the Companys leverage
ratio (as defined in the New Credit Facility generally as the ratio of total debt on the date of
determination to the Companys EBITDA, as defined, for the four quarters most recently ended prior
to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to
certain exceptions. Voluntary prepayments and commitment reductions are permitted in whole or in
part, without any premium or penalty, subject to minimum prepayment or reduction requirements.
The obligor under the New Credit Facility is CHS. All of the obligations under the
New Credit Facility are unconditionally guaranteed by the Company and certain existing and
subsequently acquired or organized domestic subsidiaries. All obligations under the New Credit
Facility and the related guarantees are secured by a perfected first priority lien or security
interest in substantially all of the assets of the Company, CHS and each
subsidiary guarantor, including equity interests held by the Company, CHS or any
subsidiary guarantor, but excluding, among others, the equity interests of non-significant
subsidiaries, syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries.
The loans under the New Credit Facility will bear interest on the outstanding unpaid principal
amount at a rate equal to an applicable percentage plus, at the Companys option, either (a) an
Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as
defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus
one-half of 1.0%, or (b) a reserve adjusted London interbank offered rate for dollars (Eurodollar
Rate) (as defined). The applicable percentage for term loans is 1.25% for Alternate Base Rate loans
and 2.25% for Eurodollar rate loans. The applicable percentage for revolving loans is initially
1.25% for Alternate Base Rate revolving loans and 2.25% for Eurodollar revolving loans, in each
case subject to reduction based on the Companys leverage ratio. Loans under the swingline
subfacility bear interest at the rate applicable to Alternate Base Rate loans under the revolving
credit facility.
13
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
12. LONG-TERM DEBT (Continued)
CHS has agreed to pay letter of credit fees equal to the applicable percentage then in
effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum
aggregate amount available to be drawn under all letters of credit outstanding under the
subfacility for letters of credit. The issuer of any letter of credit issued under the subfacility
for letters of credit will also receive a customary fronting fee and other customary processing
charges. CHS is initially obligated to pay commitment fees of 0.50% per annum (subject to
reduction based upon the Companys leverage ratio) on the unused portion of the revolving credit
facility. For purposes of this calculation, swingline loans are not treated as usage of the
revolving credit facility. CHS is also obligated to pay commitment fees of 0.50% per annum
for the first six months after the closing of the New Credit Facility, 0.75% per annum for the next
three months thereafter and 1.0% per annum thereafter, in each case on the unused amount of the
delayed draw term loan facility. The Company paid arrangement fees on the closing of the New Credit
Facility and will pay an annual administrative agent fee.
The New Credit Facility contains customary representations and warranties, subject to limitations
and exceptions, and customary covenants restricting, subject to certain exceptions, the Companys
and its subsidiaries ability to, among other things (1) declare dividends, make distributions or
redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or
grant negative pledges, (4) make loans and investments and enter into acquisitions and joint
ventures, (5) incur additional indebtedness or provide certain guarantees, (6) make capital
expenditures, (7) engage in mergers, acquisitions and asset sales, (8) conduct transactions with
affiliates, (9) alter the nature of the Companys businesses, (10) grant certain guarantees with
respect to physician practices, (11) engage in sale and leaseback transactions or (12) change the
Companys fiscal year. The Company is also required to comply with specified financial covenants
(consisting of a leverage ratio and an interest coverage ratio) and various affirmative covenants.
Events of default under the New Credit Facility include, but are not limited to, (1) the Companys
failure to pay principal, interest, fees or other amounts under the credit agreement when due
(taking into account any applicable grace period), (2) any representation or warranty proving to
have been materially incorrect when made, (3) covenant defaults subject, with respect to certain
covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6)
certain undischarged judgments (not paid within an applicable grace period), (7) a change of
control, (8) certain ERISA-related defaults, and (9) the invalidity or impairment of specified
security interests, guarantees or subordination provisions in favor of the administrative agent or
lenders under the New Credit Facility.
The Notes
were issued by CHS in connection with the Triad acquisition in the
principal amount of $3.021 billion. These Notes will mature on July 15, 2015. The Notes bear
interest at the rate of 8.875% per annum, payable semiannually in arrears on January 15 and July
15, commencing January 15, 2008. Interest on the Notes accrue from the date of original issuance.
Interest will be calculated on the basis of 360-day year comprised of twelve 30-day months.
Except as set forth below, CHS is not entitled to redeem the Notes prior to July
15, 2011.
On and after July 15, 2011, CHS is entitled, at its option, to redeem all or a
portion of the Notes upon not less than 30 nor more than 60 days notice, at the redemption prices
(expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid
interest, if any, to the redemption date (subject to the right of holders of record on the relevant
record date to receive interest due on the relevant interest payment date), if redeemed during the
12-month period commencing on July 15 of the years set forth below:
|
|
|
|
|
Period |
|
Redemption Price |
2011 |
|
|
104.438 |
% |
2012 |
|
|
102.219 |
% |
2013 and thereafter |
|
|
100.000 |
% |
14
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
12. LONG-TERM DEBT (Continued)
In addition, any time prior to July 15, 2010,
CHS is entitled, at its option, on
one or more occasions to redeem the Notes (which include additional Notes (the Additional Notes),
if any which may be issued from time to time under the indenture under which the Notes were issued)
in an aggregate principal amount not to exceed 35% of the aggregate principal amount of the Notes
(which includes Additional Notes, if any) originally issued at a redemption price (expressed as a
percentage of principal amount) of 108.875%, plus accrued and unpaid interest to the redemption
date, with the Net Cash Proceeds (as defined) from one or more Public Equity Offerings (as defined)
(provided that if the Public Equity Offering is an offering by the Company, a portion of the Net
Cash Proceeds thereof equal to the amount required to redeem any such Notes is contributed to the
equity capital of CHS); provided, however, that:
|
1) |
|
at least 65% of such aggregate principal amount
of Notes originally issued remains outstanding immediately
after the occurrence of each such redemption (other than the
Notes held, directly or indirectly, by the Company or its
subsidiaries); and |
|
|
2) |
|
each such redemption occurs within 90 days after
the date of the related Public Equity Offering. |
CHS is entitled, at its option, to redeem the Notes, in whole or in part, at any
time prior to July 15, 2011, upon not less than 30 or more than 60 days notice, at a redemption
price equal to 100% of the principal amount of Notes redeemed plus the Application Premium (as
defined), and accrued and unpaid interest, if any, as of the applicable redemption date.
Pursuant to a registration rights agreement entered into at the time of the issuance of the Notes
as a result of an exchange offer made by CHS, substantially all of the Notes
issued in July 2007 were exchanged in November 2007 for new notes (the Exchange Notes) having
terms substantially identical in all material respects to the Notes (except that the Exchange Notes
were issued under a registration statement pursuant to the 1933 Act). References to the Notes
shall also be deemed to include Exchange Notes unless the context provides otherwise.
During the quarter ended March 31, 2008, the Company repurchased on the open market and cancelled
$62.7 million of the Notes. This resulted in a loss from early extinguishment of debt of $1.3
million with an after-tax impact of $0.9 million.
As of
March 31, 2008, the availability for additional borrowings under
the New Credit
Facility was $1.050 billion (consisting of a $750 million revolving credit facility and a $300
million delayed draw term loan facility), of which $35 million was set aside for outstanding
letters of credit. CHS also has the ability to add up to $300 million of borrowing capacity
from receivable transactions (including securitizations) under the New Credit Facility which has
not yet been accessed. CHS also has the ability to amend the New Credit Facility to provide
for one or more tranches of term loans in an aggregate principal
amount of $600 million, which CHS has not yet accessed. As of
March 31, 2008, the weighted-average interest rate
under the New Credit Facility was 5.7%.
Cash paid for interest, net of interest income, was $229.1 million and $25.9 million during the
three months ended March 31, 2008 and 2007, respectively.
13. RECENT ACCOUNTING PRONOUNCEMENTS
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and
Financial Liabilities Including an Amendment of FASB Statement No. 115 (SFAS No. 159). SFAS
No. 159 expands the use of fair value accounting but does not affect existing standards that
require assets or liabilities to be carried at fair value. SFAS No. 159 permits an entity, on a
contract-by-contract basis, to make an irrevocable election to account for certain types of
financial instruments and warranty and insurance contracts at fair value, rather than historical
cost, with changes in the fair value, whether realized or unrealized, recognized in earnings. SFAS
No. 159 is effective for fiscal years beginning after November 15, 2007. The Company adopted SFAS
No. 159 as of January 1, 2008. The adoption of this statement has not had a material effect on the
Companys consolidated results of operations or consolidated financial position.
15
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
13. RECENT ACCOUNTING PRONOUNCEMENTS (Continued)
In December 2007, the FASB issued SFAS No. 141(R), Business Combinations (SFAS No. 141(R)).
SFAS No. 141(R) replaces SFAS No. 141 and addresses the recognition and accounting for identifiable
assets acquired, liabilities assumed, and noncontrolling interests in business combinations. This
standard will require more assets and liabilities to be recorded at fair value and will require
expense recognition (rather than capitalization) of certain pre-acquisition costs. This standard
also will require any adjustments to acquired deferred tax assets and liabilities occurring after
the related allocation period to be made through earnings. Furthermore, this standard requires this
treatment of acquired deferred tax assets and liabilities also be applied to acquisitions occurring
prior to the effective date of this standard. SFAS No. 141(R) is effective for fiscal years
beginning after December 15, 2008 and is required to be adopted prospectively with no early
adoption permitted. SFAS No. 141(R) will be adopted by the Company in the first quarter of 2009.
The Company is currently assessing the potential impact that SFAS No. 141(R) will have on its
consolidated results of operations or financial position.
In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial
Statements (SFAS No. 160). SFAS No. 160 addresses the accounting and reporting framework for
noncontrolling ownership interests in consolidated subsidiaries of the parent. SFAS No. 160 also
establishes disclosure requirements that clearly identify and distinguish between the interests of
the parent company and the interests of the noncontrolling owners and that require minority
ownership interests be presented separately within equity in the consolidated financial statements.
SFAS No. 160 is effective for fiscal years beginning after December 15, 2008, and will be adopted
by the Company in the first quarter of 2009. The Company is currently assessing the potential
impact that SFAS No. 160 will have on its consolidated results of operations or financial position.
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging
Activities (SFAS No. 161). SFAS No. 161 expands the disclosure requirements for derivative
instruments and for hedging activities in order to provide additional understanding of how an
entity uses derivative instruments and how they are accounted for and reported in an entitys
financial statements. The new disclosure requirements for SFAS No. 161 are effective for fiscal
years beginning after November 15, 2008, and will be adopted by the Company in the first quarter of
2009.
14. SEGMENT INFORMATION
The Company operates in three distinct operating segments, represented by the hospital operations
(which includes our general acute care hospitals and related healthcare entities that provide
inpatient and outpatient health care services), the home health agencies operations (which provide
in-home outpatient care), and our hospital management services business (which provides executive
management and consulting services to non-affliated acute care hospitals). Only the hospital
operations segment meets the criteria in SFAS No. 131, Disclosure about Segments of an Enterprise
and Related Information (SFAS No. 131), as a separate reportable segment. The financial
information for the home health agencies and management services segments do not meet the
quantitative thresholds defined in SFAS No. 131 and are combined into the corporate and all other
reportable segment.
The distribution between reportable segments of our revenues and income from continuing operations
before income taxes is summarized in the following tables (in thousands):
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended March 31, |
|
|
|
2008 |
|
|
2007 |
|
Revenues: |
|
|
|
|
|
|
|
|
Hospital operations |
|
$ |
2,664,016 |
|
|
$ |
1,130,207 |
|
Corporate and all other |
|
|
63,538 |
|
|
|
24,071 |
|
|
|
|
|
|
|
|
|
|
$ |
2,727,554 |
|
|
$ |
1,154,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes: |
|
|
|
|
|
|
|
|
Hospital operations |
|
$ |
117,892 |
|
|
$ |
113,529 |
|
Corporate and all other |
|
|
(34,164 |
) |
|
|
(20,408 |
) |
|
|
|
|
|
|
|
|
|
$ |
83,728 |
|
|
$ |
93,121 |
|
|
|
|
|
|
|
|
15. FAIR VALUE
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements (SFAS No. 157), which defines
fair value, provides a framework for measuring fair value, and expands disclosures required for fair value measurements. SFAS No. 157
applies to other accounting pronouncements that require fair value measurement; it does not require any new fair value measurements.
SFAS No. 157 is effective for fiscal years beginning after November 15, 2007, and was adopted by the Company as of January 1, 2008.
The adoption of this statement has not had a material effect on the
Companys consolidated results of operations or consolidated financial position.
In February 2008, the FASB issued FASB Statement of Position No.157-2, Effective Date of FASB Statement No. 157, (FSP 157-2). FSP 157-2
deferred the effective date of the provisions of SFAS No. 157 for all non-financial assets and non-financial liabilities to fiscal
years beginning after November 15, 2008, and will be adopted by the Company in the first quarter of 2009. The Company is currently
assessing the potential impact of SFAS No. 157 for non-financial
assets and non-financial liabilities on its consolidated
statements of financial position and results of operations.
Fair Value Hierarchy
SFAS No. 157 classifies the inputs used to measure fair value into the following hierarchy:
|
|
|
Level 1:
|
|
Quoted market prices in active markets for identical assets or liabilities. |
Level 2:
|
|
Observable market-based inputs or unobservable inputs that are corroborated by market data. |
Level 3:
|
|
Unobservable inputs that are supported by little or no market activity and are significant to the
fair value of the assets or liabilities. Level 3 includes values determined using pricing models,
discounted cash flow methodologies, or similar techniques reflecting the Companys own assumptions. |
The following table sets forth, by level within the fair value hierarchy,
the financial assets and liabilities recorded at fair value on a recurring basis as of March 31, 2008
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Available-for-sale securities |
|
$ |
7,968 |
|
|
$ |
7,968 |
|
|
$ |
|
|
|
$ |
|
|
Trading securities |
|
|
31,749 |
|
|
|
31,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
39,717 |
|
|
$ |
39,717 |
|
|
$ |
|
|
|
$ |
|
|
Fair value of interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rate swap
agreements |
|
$ |
290,553 |
|
|
$ |
|
|
|
$ |
290,553 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
$ |
290,553 |
|
|
$ |
|
|
|
$ |
290,553 |
|
|
$ |
|
|
Available-for-sale securities and trading securities classified as Level 1 are measured using quoted market prices. The fair value
of the Companys interest rate swap agreements are classified as Level 2, and are estimated using an income approach based on
the LIBOR swap rate, which is observable at commonly quoted intervals for the full term of the swap.
16. CONTINGENCIES
The Company is a party to various legal proceedings incidental to its business. In the opinion of
management, any ultimate liability with respect to these actions will not have a material adverse
effect on the Companys consolidated financial position, cash flows or results of operations. In
addition, in connection with the closing of the Triad acquisition on July 25, 2007, the
16
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
16. CONTINGENCIES (Continued)
Company has assumed both recorded and unrecorded contingencies of Triad. The Companys management
is not aware of any unrecorded contingencies assumed in connection with the Triad acquisition,
whose ultimate outcome will have a material adverse effect on the Companys consolidated financial
position, cash flows or results of operations.
In a letter dated October 4, 2007, the Civil Division of the Department of Justice notified the
Company that, as a result of an investigation into the way in which different state Medicaid
programs apply to the federal government for matching or supplemental funds that are ultimately
used to pay for a small portion of the services provided to Medicaid and indigent patients, it
believes the Company and three of its New Mexico hospitals have caused the State of New Mexico to
submit improper claims for federal funds in violation of the federal False Claims Act. In a letter
dated January 22, 2008, the Civil Division notified the Company that based on its investigation, it
has calculated that these three hospitals received ineligible federal participation payments from
August 2000 to June 2006 of approximately $27.5 million. The Civil Division also advised the
Company that were it to proceed to trial, it would seek treble damages plus an appropriate penalty
for each of the violations of the False Claims Act. The Company continues to believe that it has
not violated the False Claims Act, and is continuing discussions with the Civil Division in an
effort to resolve this matter.
17. SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
In connection with the consummation of the Triad acquisition, the Company obtained $7.215 billion
of senior secured financing under the New Credit Facility and CHS issued the Notes
in the aggregate principal amount of $3.021 billion. The Notes are senior unsecured obligations of
CHS and are guaranteed on a senior basis by the Company and by certain of the
Companys domestic subsidiaries. The Notes are fully and unconditionally guaranteed by the Company
and certain existing and subsequently acquired or organized domestic subsidiaries. Such guarantees
are joint and several. The following condensed consolidating financial statements present the
Company (as guarantor), CHS (as the issuer), the subsidiary guarantors, the
subsidiary non-guarantors and eliminations. This condensed consolidating financial information has
been prepared and presented in accordance with SEC Regulation S-X Rule 3-10 Financial Statements
of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.
17
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Condensed Consolidated Balance Sheet
March 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
(In thousands, except share data) |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
|
|
|
$ |
|
|
|
$ |
213,879 |
|
|
$ |
|
|
|
$ |
(49,526 |
) |
|
$ |
164,353 |
|
Patient accounts receivable, net of allowance
for doubtful accounts |
|
|
|
|
|
|
|
|
|
|
1,021,244 |
|
|
|
604,414 |
|
|
|
|
|
|
|
1,625,658 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
164,622 |
|
|
|
99,439 |
|
|
|
|
|
|
|
264,061 |
|
Deferred income taxes |
|
|
113,741 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
113,741 |
|
Prepaid expenses and taxes |
|
|
|
|
|
|
58 |
|
|
|
180,024 |
|
|
|
13,930 |
|
|
|
|
|
|
|
194,012 |
|
Other current assets |
|
|
|
|
|
|
390 |
|
|
|
129,601 |
|
|
|
114,576 |
|
|
|
|
|
|
|
244,567 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
113,741 |
|
|
|
448 |
|
|
|
1,709,370 |
|
|
|
832,359 |
|
|
|
(49,526 |
) |
|
|
2,606,392 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
|
|
|
|
|
|
|
|
|
3,343,680 |
|
|
|
2,094,717 |
|
|
|
|
|
|
|
5,438,397 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
21,126 |
|
|
|
|
|
|
|
2,435,773 |
|
|
|
1,918,394 |
|
|
|
|
|
|
|
4,375,293 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets, net |
|
|
|
|
|
|
186,076 |
|
|
|
487,395 |
|
|
|
238,796 |
|
|
|
|
|
|
|
912,267 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment in subsidiaries |
|
|
1,506,013 |
|
|
|
1,234,270 |
|
|
|
3,680,406 |
|
|
|
|
|
|
|
(6,420,689 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
1,640,880 |
|
|
$ |
1,420,794 |
|
|
$ |
11,656,624 |
|
|
$ |
5,084,266 |
|
|
$ |
(6,470,215 |
) |
|
$ |
13,332,349 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current maturities of long-term debt |
|
$ |
|
|
|
$ |
|
|
|
$ |
14,667 |
|
|
$ |
4,809 |
|
|
$ |
|
|
|
$ |
19,476 |
|
Accounts payable |
|
|
|
|
|
|
41 |
|
|
|
339,276 |
|
|
|
171,646 |
|
|
|
(49,526 |
) |
|
|
461,437 |
|
Current income taxes payable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued liabilities |
|
|
|
|
|
|
|
|
|
|
434,906 |
|
|
|
296,365 |
|
|
|
|
|
|
|
731,271 |
|
Interest payable (receivable) |
|
|
|
|
|
|
2,599 |
|
|
|
88,205 |
|
|
|
(362 |
) |
|
|
|
|
|
|
90,442 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
|
|
|
|
2,640 |
|
|
|
877,054 |
|
|
|
472,458 |
|
|
|
(49,526 |
) |
|
|
1,302,626 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt payable (receivable) |
|
|
4 |
|
|
|
4,325,296 |
|
|
|
4,509,849 |
|
|
|
51,206 |
|
|
|
|
|
|
|
8,886,355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
407,947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
407,947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other long-term liabilities |
|
|
195 |
|
|
|
284,848 |
|
|
|
198,936 |
|
|
|
195,743 |
|
|
|
|
|
|
|
679,722 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interests in equity of
consolidated subsidiaries |
|
|
|
|
|
|
|
|
|
|
2,156 |
|
|
|
381,973 |
|
|
|
|
|
|
|
384,129 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intercompany (receivable) payable |
|
|
(438,836 |
) |
|
|
(4,698,000 |
) |
|
|
4,841,662 |
|
|
|
4,101,680 |
|
|
|
(3,806,506 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock |
|
|
972 |
|
|
|
|
|
|
|
1 |
|
|
|
2 |
|
|
|
(3 |
) |
|
|
972 |
|
Additional paid-in capital |
|
|
1,247,241 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,247,241 |
|
Treasury stock, at cost, 975,549 shares |
|
|
(6,678 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,678 |
) |
Accumulated other comprehensive income (loss) |
|
|
(188,037 |
) |
|
|
(188,037 |
) |
|
|
(5,734 |
) |
|
|
|
|
|
|
193,771 |
|
|
|
(188,037 |
) |
Retained earnings |
|
|
618,072 |
|
|
|
1,694,047 |
|
|
|
1,232,700 |
|
|
|
(118,796 |
) |
|
|
(2,807,951 |
) |
|
|
618,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
1,671,570 |
|
|
|
1,506,010 |
|
|
|
1,226,967 |
|
|
|
(118,794 |
) |
|
|
(2,614,183 |
) |
|
|
1,671,570 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
1,640,880 |
|
|
$ |
1,420,794 |
|
|
$ |
11,656,624 |
|
|
$ |
5,084,266 |
|
|
$ |
(6,470,215 |
) |
|
$ |
13,332,349 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Condensed Consolidated Balance Sheet
December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
(In thousands, except share data) |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
|
|
|
$ |
|
|
|
$ |
114,075 |
|
|
$ |
18,799 |
|
|
$ |
|
|
|
$ |
132,874 |
|
Patient accounts receivable, net of allowance
for doubtful accounts |
|
|
|
|
|
|
|
|
|
|
954,106 |
|
|
|
579,692 |
|
|
|
|
|
|
|
1,533,798 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
163,961 |
|
|
|
98,942 |
|
|
|
|
|
|
|
262,903 |
|
Deferred income taxes |
|
|
113,741 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
113,741 |
|
Prepaid expenses and taxes |
|
|
|
|
|
|
102 |
|
|
|
156,733 |
|
|
|
12,921 |
|
|
|
|
|
|
|
169,756 |
|
Other current assets |
|
|
|
|
|
|
|
|
|
|
129,147 |
|
|
|
210,679 |
|
|
|
|
|
|
|
339,826 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
113,741 |
|
|
|
102 |
|
|
|
1,518,022 |
|
|
|
921,033 |
|
|
|
|
|
|
|
2,552,898 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
|
|
|
|
|
|
|
|
|
3,667,487 |
|
|
|
1,845,087 |
|
|
|
|
|
|
|
5,512,574 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
96,671 |
|
|
|
|
|
|
|
2,162,601 |
|
|
|
1,988,442 |
|
|
|
|
|
|
|
4,247,714 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets, net |
|
|
|
|
|
|
189,140 |
|
|
|
276,589 |
|
|
|
714,728 |
|
|
|
|
|
|
|
1,180,457 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment in subsidiaries |
|
|
1,519,952 |
|
|
|
1,464,944 |
|
|
|
4,968,905 |
|
|
|
|
|
|
|
(7,953,801 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
1,730,364 |
|
|
$ |
1,654,186 |
|
|
$ |
12,593,604 |
|
|
$ |
5,469,290 |
|
|
$ |
(7,953,801 |
) |
|
$ |
13,493,643 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current maturities of long-term debt |
|
$ |
|
|
|
$ |
|
|
|
$ |
16,603 |
|
|
$ |
4,107 |
|
|
$ |
|
|
|
$ |
20,710 |
|
Accounts payable |
|
|
|
|
|
|
19 |
|
|
|
276,503 |
|
|
|
216,171 |
|
|
|
|
|
|
|
492,693 |
|
Current income taxes payable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes current |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued liabilities |
|
|
|
|
|
|
|
|
|
|
437,808 |
|
|
|
342,892 |
|
|
|
|
|
|
|
780,700 |
|
Interest payable (receivable) |
|
|
|
|
|
|
153,085 |
|
|
|
8,042 |
|
|
|
(7,295 |
) |
|
|
|
|
|
|
153,832 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
|
|
|
|
153,104 |
|
|
|
738,956 |
|
|
|
555,875 |
|
|
|
|
|
|
|
1,447,935 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt payable (receivable) |
|
|
4 |
|
|
|
4,487,090 |
|
|
|
4,633,801 |
|
|
|
(43,528 |
) |
|
|
|
|
|
|
9,077,367 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
407,947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
407,947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other long-term liabilities |
|
|
(2,519 |
) |
|
|
121,482 |
|
|
|
188,316 |
|
|
|
176,180 |
|
|
|
|
|
|
|
483,459 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interests in equity of consolidated subsidiaries |
|
|
|
|
|
|
|
|
|
|
13,491 |
|
|
|
352,640 |
|
|
|
|
|
|
|
366,131 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intercompany (receivable) payable |
|
|
(385,872 |
) |
|
|
(4,627,439 |
) |
|
|
5,956,358 |
|
|
|
4,562,215 |
|
|
|
(5,505,262 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock |
|
|
966 |
|
|
|
|
|
|
|
1 |
|
|
|
2 |
|
|
|
(3 |
) |
|
|
966 |
|
Additional paid-in capital |
|
|
1,240,308 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,240,308 |
|
Treasury stock, at cost, 975,549 shares |
|
|
(6,678 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,678 |
) |
Accumulated other comprehensive income (loss) |
|
|
(81,737 |
) |
|
|
(81,737 |
) |
|
|
(3,990 |
) |
|
|
|
|
|
|
85,727 |
|
|
|
(81,737 |
) |
Retained earnings |
|
|
557,945 |
|
|
|
1,601,686 |
|
|
|
1,066,671 |
|
|
|
(134,094 |
) |
|
|
(2,534,263 |
) |
|
|
557,945 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
1,710,804 |
|
|
|
1,519,949 |
|
|
|
1,062,682 |
|
|
|
(134,092 |
) |
|
|
(2,448,539 |
) |
|
|
1,710,804 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
1,730,364 |
|
|
$ |
1,654,186 |
|
|
$ |
12,593,604 |
|
|
$ |
5,469,290 |
|
|
$ |
(7,953,801 |
) |
|
$ |
13,493,643 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Condensed Consolidated Statement of Income
Three Months Ended March 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
(In thousands) |
|
Net operating revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
1,688,744 |
|
|
$ |
1,038,810 |
|
|
$ |
|
|
|
$ |
2,727,554 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
|
|
|
|
|
|
|
|
638,641 |
|
|
|
449,129 |
|
|
|
|
|
|
|
1,087,770 |
|
Provision for bad debts |
|
|
|
|
|
|
|
|
|
|
193,890 |
|
|
|
103,190 |
|
|
|
|
|
|
|
297,080 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
226,130 |
|
|
|
160,279 |
|
|
|
|
|
|
|
386,409 |
|
Other operating expenses |
|
|
|
|
|
|
|
|
|
|
300,191 |
|
|
|
225,976 |
|
|
|
|
|
|
|
526,167 |
|
Rent |
|
|
|
|
|
|
|
|
|
|
31,301 |
|
|
|
28,556 |
|
|
|
|
|
|
|
59,857 |
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
77,785 |
|
|
|
44,930 |
|
|
|
|
|
|
|
122,715 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,467,938 |
|
|
|
1,012,060 |
|
|
|
|
|
|
|
2,479,998 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
|
|
|
|
|
|
|
|
220,806 |
|
|
|
26,750 |
|
|
|
|
|
|
|
247,556 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
|
|
|
|
72,577 |
|
|
|
75,937 |
|
|
|
17,188 |
|
|
|
|
|
|
|
165,702 |
|
Loss from early extinguishment of debt |
|
|
|
|
|
|
1,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,328 |
|
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
(193 |
) |
|
|
9,875 |
|
|
|
|
|
|
|
9,682 |
|
Equity in earnings of subsididary |
|
|
(92,362 |
) |
|
|
(166,267 |
) |
|
|
(20,967 |
) |
|
|
|
|
|
|
266,712 |
|
|
|
(12,884 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
(loss) from continuing operations
before income taxes |
|
|
92,362 |
|
|
|
92,362 |
|
|
|
166,029 |
|
|
|
(313 |
) |
|
|
(266,712 |
) |
|
|
83,728 |
|
Provision for income taxes |
|
|
32,235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
(loss) from continuing operations |
|
|
60,127 |
|
|
|
92,362 |
|
|
|
166,029 |
|
|
|
(313 |
) |
|
|
(266,712 |
) |
|
|
51,493 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations, net of taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations of
hospitals sold and held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(983 |
) |
|
|
|
|
|
|
(983 |
) |
Gain on sale of hospitals, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,617 |
|
|
|
|
|
|
|
9,617 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income on discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,634 |
|
|
|
|
|
|
|
8,634 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
60,127 |
|
|
$ |
92,362 |
|
|
$ |
166,029 |
|
|
$ |
8,321 |
|
|
$ |
(266,712 |
) |
|
$ |
60,127 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Condensed Consolidated Statement of Income
Three Months Ended March 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
(In thousands) |
|
Net operating revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
921,231 |
|
|
$ |
233,047 |
|
|
$ |
|
|
|
$ |
1,154,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
|
|
|
|
|
|
|
|
352,482 |
|
|
|
110,283 |
|
|
|
|
|
|
|
462,765 |
|
Provision for bad debts |
|
|
|
|
|
|
|
|
|
|
105,540 |
|
|
|
22,514 |
|
|
|
|
|
|
|
128,054 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
107,117 |
|
|
|
27,177 |
|
|
|
|
|
|
|
134,294 |
|
Other operating expenses |
|
|
|
|
|
|
|
|
|
|
180,001 |
|
|
|
54,164 |
|
|
|
|
|
|
|
234,165 |
|
Rent |
|
|
|
|
|
|
|
|
|
|
17,679 |
|
|
|
7,077 |
|
|
|
|
|
|
|
24,756 |
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
40,591 |
|
|
|
7,906 |
|
|
|
|
|
|
|
48,497 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
803,410 |
|
|
|
229,121 |
|
|
|
|
|
|
|
1,032,531 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
|
|
|
|
|
|
|
|
117,821 |
|
|
|
3,926 |
|
|
|
|
|
|
|
121,747 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
|
|
|
|
|
|
|
|
21,681 |
|
|
|
6,752 |
|
|
|
|
|
|
|
28,433 |
|
Equity in earnings of subsididary |
|
|
(90,156 |
) |
|
|
(90,156 |
) |
|
|
6,499 |
|
|
|
|
|
|
|
173,813 |
|
|
|
|
|
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
193 |
|
|
|
|
|
|
|
193 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
before income taxes |
|
|
90,156 |
|
|
|
90,156 |
|
|
|
89,641 |
|
|
|
(3,019 |
) |
|
|
(173,813 |
) |
|
|
93,121 |
|
Provision for income taxes |
|
|
35,832 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,832 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
54,324 |
|
|
|
90,156 |
|
|
|
89,641 |
|
|
|
(3,019 |
) |
|
|
(173,813 |
) |
|
|
57,289 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations, net of taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations of
hospitals sold and held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,965 |
) |
|
|
|
|
|
|
(2,965 |
) |
Loss on sale of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,965 |
) |
|
|
|
|
|
|
(2,965 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
54,324 |
|
|
$ |
90,156 |
|
|
$ |
89,641 |
|
|
$ |
(5,984 |
) |
|
$ |
(173,813 |
) |
|
$ |
54,324 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Condensed Consolidated Statement of Cash Flows
Three Months Ended March 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
(In thousands) |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
60,127 |
|
|
$ |
92,362 |
|
|
$ |
166,029 |
|
|
$ |
8,321 |
|
|
$ |
(266,712 |
) |
|
$ |
60,127 |
|
Adjustments to reconcile net income to net cash
provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
77,785 |
|
|
|
44,693 |
|
|
|
|
|
|
|
122,478 |
|
Stock-based compenstion expense |
|
|
13,246 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,246 |
|
Excess tax benefits relating to stock-based compensation |
|
|
947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
947 |
|
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
(193 |
) |
|
|
9,875 |
|
|
|
|
|
|
|
9,682 |
|
Gain on sale of hospitals, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(12,885 |
) |
|
|
|
|
|
|
(12,885 |
) |
Other non-cash expenses, net |
|
|
|
|
|
|
(1,678 |
) |
|
|
(2,666 |
) |
|
|
7,114 |
|
|
|
|
|
|
|
2,770 |
|
Changes in operating assets and liabilities, net
of effects of acquisitions and divestitures: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient accounts receivable |
|
|
|
|
|
|
|
|
|
|
(72,727 |
) |
|
|
(27,330 |
) |
|
|
|
|
|
|
(100,057 |
) |
Supplies, prepaid expenses and other current assets |
|
|
|
|
|
|
(346 |
) |
|
|
58,220 |
|
|
|
(84,458 |
) |
|
|
|
|
|
|
(26,584 |
) |
Accounts
payable, accrued liabilities and income taxes |
|
|
69,142 |
|
|
|
(91,198 |
) |
|
|
217,690 |
|
|
|
(228,073 |
) |
|
|
(49,526 |
) |
|
|
(81,965 |
) |
Advances to subsidiaries, net of return on investment |
|
|
(39,024 |
) |
|
|
160,111 |
|
|
|
173,804 |
|
|
|
(561,603 |
) |
|
|
266,712 |
|
|
|
|
|
Other |
|
|
(103,585 |
) |
|
|
4,775 |
|
|
|
(296,581 |
) |
|
|
416,510 |
|
|
|
|
|
|
|
21,119 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash
provided by (used in) operating activities |
|
|
853 |
|
|
|
164,026 |
|
|
|
321,361 |
|
|
|
(427,836 |
) |
|
|
(49,526 |
) |
|
|
8,878 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions of facilities and other related equipment |
|
|
|
|
|
|
|
|
|
|
(1,685 |
) |
|
|
(20 |
) |
|
|
|
|
|
|
(1,705 |
) |
Purchases of property and equipment |
|
|
|
|
|
|
|
|
|
|
(84,607 |
) |
|
|
(52,464 |
) |
|
|
|
|
|
|
(137,071 |
) |
Disposition of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
365,680 |
|
|
|
|
|
|
|
365,680 |
|
Proceeds from sale of property and equipment |
|
|
|
|
|
|
|
|
|
|
904 |
|
|
|
12,813 |
|
|
|
|
|
|
|
13,717 |
|
Investment in other assets |
|
|
|
|
|
|
|
|
|
|
(12,889 |
) |
|
|
(43,660 |
) |
|
|
|
|
|
|
(56,549 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
|
|
|
|
|
|
|
|
|
|
(98,277 |
) |
|
|
282,349 |
|
|
|
|
|
|
|
184,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
|
94 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
94 |
|
Deferred financing costs |
|
|
|
|
|
|
(2,232 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,232 |
) |
Excess tax benefits relating to stock-based compensation |
|
|
(947 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(947 |
) |
Proceeds from minority investors in joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,881 |
|
|
|
|
|
|
|
12,881 |
|
Redemption of minority investments in joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions to minority investors in joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,524 |
) |
|
|
|
|
|
|
(7,524 |
) |
Borrowings under credit agreement |
|
|
|
|
|
|
25,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000 |
|
(Repayments)
borrowings of long-term indebtedness |
|
|
|
|
|
|
(186,794 |
) |
|
|
(123,280 |
) |
|
|
121,331 |
|
|
|
|
|
|
|
(188,743 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities |
|
|
(853 |
) |
|
|
(164,026 |
) |
|
|
(123,280 |
) |
|
|
126,688 |
|
|
|
|
|
|
|
(161,471 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
99,804 |
|
|
|
(18,799 |
) |
|
|
(49,526 |
) |
|
|
31,479 |
|
Cash and cash equivalents at beginning of period |
|
|
|
|
|
|
|
|
|
|
114,075 |
|
|
|
18,799 |
|
|
|
|
|
|
|
132,874 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
|
|
|
$ |
|
|
|
$ |
213,879 |
|
|
$ |
|
|
|
$ |
(49,526 |
) |
|
$ |
164,353 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Condensed Consolidated Statement of Cash Flows
Three Months Ended March 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
|
|
(In thousands) |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
54,324 |
|
|
$ |
90,156 |
|
|
$ |
89,641 |
|
|
$ |
(5,984 |
) |
|
$ |
(173,813 |
) |
|
$ |
54,324 |
|
Adjustments to reconcile net income to net cash
provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
40,591 |
|
|
|
10,679 |
|
|
|
|
|
|
|
51,270 |
|
Stock-based compenstion expense |
|
|
6,330 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,330 |
|
Excess tax benefits relating to stock-based compensation |
|
|
(758 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(758 |
) |
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
193 |
|
|
|
|
|
|
|
193 |
|
Gain on sale of hospitals, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other non-cash expenses, net |
|
|
|
|
|
|
|
|
|
|
98 |
|
|
|
34 |
|
|
|
|
|
|
|
132 |
|
Changes in operating assets and liabilities, net
of effects of acquisitions and divestitures: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient accounts receivable |
|
|
|
|
|
|
|
|
|
|
(21,621 |
) |
|
|
(11,701 |
) |
|
|
|
|
|
|
(33,322 |
) |
Supplies, prepaid expenses and other current assets |
|
|
|
|
|
|
|
|
|
|
(3,618 |
) |
|
|
(4,249 |
) |
|
|
|
|
|
|
(7,867 |
) |
Accounts payable, accrued liabilities and income taxes |
|
|
(97,606 |
) |
|
|
(730 |
) |
|
|
40,813 |
|
|
|
103,211 |
|
|
|
|
|
|
|
45,688 |
|
Advances to subsidiaries, net of return on investment |
|
|
(61,653 |
) |
|
|
(86,549 |
) |
|
|
(42,874 |
) |
|
|
17,263 |
|
|
|
173,813 |
|
|
|
|
|
Other |
|
|
95,205 |
|
|
|
1,137 |
|
|
|
5,180 |
|
|
|
(97,165 |
) |
|
|
|
|
|
|
4,357 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash
provided by (used in) operating activities |
|
|
(4,158 |
) |
|
|
4,014 |
|
|
|
108,210 |
|
|
|
12,281 |
|
|
|
|
|
|
|
120,347 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions of facilities and other related equipment |
|
|
|
|
|
|
|
|
|
|
(41,141 |
) |
|
|
(2,898 |
) |
|
|
|
|
|
|
(44,039 |
) |
Purchases of property and equipment |
|
|
|
|
|
|
|
|
|
|
(37,521 |
) |
|
|
(7,268 |
) |
|
|
|
|
|
|
(44,789 |
) |
Disposition of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of property and equipment |
|
|
|
|
|
|
|
|
|
|
77 |
|
|
|
57 |
|
|
|
|
|
|
|
134 |
|
Investment in other assets |
|
|
|
|
|
|
|
|
|
|
(6,570 |
) |
|
|
(481 |
) |
|
|
|
|
|
|
(7,051 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
|
|
|
|
|
|
|
|
|
|
(85,155 |
) |
|
|
(10,590 |
) |
|
|
|
|
|
|
(95,745 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
|
3,311 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,311 |
|
Deferred financing costs |
|
|
|
|
|
|
(14 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(14 |
) |
Excess tax benefits relating to stock-based compensation |
|
|
758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
758 |
|
Proceeds from minority investors in joint ventures |
|
|
89 |
|
|
|
|
|
|
|
|
|
|
|
930 |
|
|
|
|
|
|
|
1,019 |
|
Redemption of minority investments in joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,253 |
) |
|
|
|
|
|
|
(1,253 |
) |
Distributions to minority investors in joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,079 |
) |
|
|
|
|
|
|
(1,079 |
) |
Borrowings under credit agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayments of long-term indebtedness |
|
|
|
|
|
|
(4,000 |
) |
|
|
(827 |
) |
|
|
(205 |
) |
|
|
|
|
|
|
(5,032 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities |
|
|
4,158 |
|
|
|
(4,014 |
) |
|
|
(827 |
) |
|
|
(1,607 |
) |
|
|
|
|
|
|
(2,290 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
22,228 |
|
|
|
84 |
|
|
|
|
|
|
|
22,312 |
|
Cash and cash equivalents at beginning of period |
|
|
|
|
|
|
|
|
|
|
28,560 |
|
|
|
12,006 |
|
|
|
|
|
|
|
40,566 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
|
|
|
$ |
|
|
|
$ |
50,788 |
|
|
$ |
12,090 |
|
|
$ |
|
|
|
$ |
62,878 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
You should read this discussion together with our unaudited condensed consolidated financial
statements and accompanying notes included herein.
Unless the context otherwise requires, Community Health Systems, the Company we, us and
our refer to Community Health Systems, Inc. and its consolidated subsidiaries.
Executive Overview
We are the
largest publicly traded operator of hospitals in the United States in
terms of number of facilities and net operating revenues. We provide
healthcare services through these hospitals that we own and operate in non-urban and selected urban
markets. We generate revenue primarily by providing a broad range of general hospital healthcare
services to patients in the communities in which we are located. We currently have 115 general
acute care hospitals included in continuing operations. In addition, we own four home health
agencies, located in markets where we do not operate a hospital and through our wholly-owned
subsidiary, Quorum Health Resources, LLC (QHR), we provide management and consulting services to
non-affiliated general acute care hospitals located throughout the United States. We are paid for
our services by governmental agencies, private insurers and directly by the patients we serve.
Effective July 25, 2007, we completed our acquisition of Triad Hospitals Inc., or Triad, for an
aggregate consideration of $6.836 billion, including $1.686 billion of assumed indebtedness. In
connection with this acquisition, one of our subsidiaries issued $3.021 billion principal amount of
8.875% senior notes due 2015 (the Notes) and we entered into a new $7.215 billion credit facility
(the New Credit Facility) consisting of a $6.065 billion term loan, a $750 million revolving
credit facility and a $400 million delayed draw term loan facility. The proceeds of these
financings were used to pay the cash consideration under the merger agreement and to refinance
substantially all of both the assumed indebtedness and our existing indebtedness and to pay related
fees and expenses. The delayed draw term loan facility was reduced in the fourth quarter of 2007,
per our request, from $400 million to $300 million. The revolving credit facility and the delayed
draw term loan facility remain available to us for future acquisitions, working capital, and
general corporate purposes. We believe the acquisition of Triad will benefit us since it has
expanded the number of markets we serve, expanded our operations into five states where we
previously did not operate, and reduced our concentration of credit risk in any one state. We also
believe that synergies obtained from eliminating duplicate corporate functions and centralizing
many support functions will allow us to improve Triads margins. As of December 31, 2007, two of
the former Triad hospitals had been sold and six other hospitals formerly owned by Triad along with
six hospitals owned by us had been identified as available for sale. During the three months ended
March 31, 2008, we completed the sale of eleven of these hospitals that were available for sale as
of December 31, 2007. Accordingly, these hospitals have been classified in discontinued operations
in the condensed consolidated statements of income for the three month period ended March 31, 2008
and three month period ended March 31, 2007 to the extent that the hospitals were owned by the
Company during the respective periods.
With the exception of the previously announced definitive agreement to acquire a two hospital
system in Spokane, Washington, we have not recently pursued additional acquisition targets, in
order to focus on the integration of the Triad acquisition. We anticipate this focus on integration
will continue throughout 2008. The acquisition of the two hospital system in Spokane is pending
governmental approval and is expected to be completed later in 2008. During the three months ended
March 31, 2008, we have realized approximately $35 million of our estimated synergies related to
this acquisition. We continue to believe our integration is on track and we anticipate recognizing
all of the anticipated synergies.
For the three months ended March 31, 2008, we generated $2.728 billion in net operating revenues, a
growth of 136.3% over the three months ended March 31, 2007, and $60.1 million of net income, an
increase of 10.7% over the three months ended March 31, 2007. For the three months ended March 31,
2008, consolidated admissions increased 111.1% and adjusted admissions increased 102.0% over the
three months ended March 31, 2007. The increases in net operating revenue and volume are due in
part to our acquisition of the former Triad hospitals, as well as a benefit from a strong flu
season.
We believe there continues to be ample opportunity for growth in substantially all of our markets
by decreasing the need for patients to travel outside their communities for health care services.
Furthermore, we continue to strive to improve operating efficiencies and procedures in order to
improve our profitability at all of our hospitals.
24
Sources of Consolidated Net Operating Revenue
The following table presents the approximate percentages of net operating revenue derived from
Medicare, Medicaid, managed care and other third party payors, and self-pay for the periods
indicated. The data for the periods presented are not strictly comparable due to the significant
effect that hospital acquisitions have had on these statistics.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, |
|
|
2008 |
|
2007 |
Medicare |
|
|
28.5 |
% |
|
|
30.9 |
% |
Medicaid |
|
|
8.3 |
% |
|
|
10.2 |
% |
Managed Care and other
third party payors |
|
|
52.6 |
% |
|
|
46.3 |
% |
Self-pay |
|
|
10.6 |
% |
|
|
12.6 |
% |
|
|
|
|
|
|
|
|
|
Total |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
Net operating revenues include amounts estimated by management to be reimbursable by Medicare and
Medicaid under prospective payment systems and provisions of cost-based reimbursement and other
payment methods. In addition, we are reimbursed by non-governmental payors using a variety of
payment methodologies. Amounts we receive for treatment of patients covered by these programs are
generally less than the standard billing rates. We account for the differences between the
estimated program reimbursement rates and the standard billing rates as contractual allowance
adjustments, which we deduct from gross revenues to arrive at net operating revenues. Final
settlements under some of these programs are subject to adjustment based on administrative review
and audit by third parties. We account for adjustments to previous program reimbursement estimates
as contractual adjustments and report them in the periods that such adjustments become known.
Adjustments related to final settlements or appeals that increased revenue were insignificant in
each of the three month periods ended March 31, 2008 and 2007. In the future, we expect the
percentage of revenues received from the Medicare program to increase due to the general aging of
the population.
The payment rates under the Medicare program for inpatient acute services are based on a
prospective payment system, depending upon the diagnosis of a patients condition. These rates are
indexed for inflation annually, although increases have historically been less than actual
inflation. Reductions in the rate of increase in Medicare reimbursement may cause our net operating
revenue growth to decline. The Medicare Prescription Drug, Improvement and Modernization Act of
2003 provides a broad range of provider payment benefits; however, federal government spending in
excess of federal budgetary provisions considered in passage of the Medicare Prescription Drug,
Improvement and Modernization Act of 2003 could result in future deficit spending for the Medicare
system, which could cause future payments under the Medicare system to decline.
In addition, specified managed care programs, insurance companies, and employers are actively
negotiating the amounts paid to hospitals. The trend toward increased enrollment in managed care
may adversely affect our net operating revenue growth.
Results of Operations
Our hospitals offer a variety of services involving a broad range of inpatient and outpatient
medical and surgical services. These include orthopedics, cardiology, occupational medicine,
diagnostic services, emergency services, rehabilitation treatment, home health and skilled nursing.
The strongest demand for hospital services generally occurs during January through April and the
weakest demand for these services occurs during the summer months. Accordingly, eliminating the
effect of new acquisitions, our net operating revenues and earnings are historically highest during
the first quarter and lowest during the third quarter.
25
The following tables summarize, for the periods indicated, selected operating data.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, |
|
|
2008 |
|
2007 |
Consolidated (a) |
|
|
|
|
|
|
|
|
Net operating revenues |
|
|
100.0 |
% |
|
|
100.0 |
% |
Operating expenses (b) |
|
|
86.5 |
|
|
|
85.3 |
|
Depreciation and amortization |
|
|
4.5 |
|
|
|
4.2 |
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
9.0 |
|
|
|
10.5 |
|
Interest expense, net |
|
|
(6.1 |
) |
|
|
(2.4 |
) |
Minority interest in earnings |
|
|
(0.3 |
) |
|
|
|
|
Equity in earnings of unconsolidated
affiliates |
|
|
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
3.1 |
|
|
|
8.1 |
|
Provision for income taxes |
|
|
(1.2 |
) |
|
|
(3.1 |
) |
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
1.9 |
|
|
|
5.0 |
|
Income (loss) on discontinued operations |
|
|
0.3 |
|
|
|
(0.3 |
) |
|
|
|
|
|
|
|
|
|
Net Income |
|
|
2.2 |
% |
|
|
4.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
March 31, 2008 |
|
|
|
|
Percentage increase (decrease) from same period
prior year (a): |
|
|
|
|
|
|
|
|
Net operating revenues |
|
|
136.3 |
% |
|
|
|
|
Admissions |
|
|
111.1 |
|
|
|
|
|
Adjusted admissions (c) |
|
|
102.0 |
|
|
|
|
|
Average length of stay |
|
|
7.3 |
|
|
|
|
|
Net Income (d) |
|
|
10.7 |
|
|
|
|
|
Same-store percentage increase
from same period prior year (a)(e): |
|
|
|
|
|
|
|
|
Net operating revenues |
|
|
5.7 |
% |
|
|
|
|
Admissions |
|
|
3.8 |
|
|
|
|
|
Adjusted admissions (c) |
|
|
3.8 |
|
|
|
|
|
|
|
|
(a) |
|
Pursuant to Statement of Financial Accounting Standards (SFAS) No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets, we have restated our prior period financial
statements and statistical results to reflect as discontinued operations those seven hospitals
that were in discontinued operations during the three months ended March 31, 2008 which were
also owned or leased during the three months ended March 31, 2007. |
|
(b) |
|
Operating expenses include salaries and benefits, provision for bad debts, supplies, rent and
other operating expenses. |
|
(c) |
|
Adjusted admissions is a general measure of combined inpatient and outpatient volume. We
computed adjusted admissions by multiplying admissions by gross patient revenues and then
dividing that number by gross inpatient revenues. |
|
(d) |
|
Includes loss from operations of discontinued hospitals and gain on sale of discontinued
hospitals. |
|
(e) |
|
Includes former Triad hospitals during the comparable periods and other acquired hospitals to
the extent we operated them in both years. |
Three months Ended March 31, 2008 Compared to Three months Ended March 31, 2007
Net operating revenues increased $1.574 billion to $2.728 billion for the three months ended March
31, 2008, from $1.154 billion for the three months ended March 31, 2007. $1.463 billion of this
increase was contributed by
hospitals acquired in the Triad acquisition that remain in continuing operations, $76 million was
contributed by other hospitals acquired in 2007 and $34 million, an increase of 2.9%, was
contributed by hospitals that we owned throughout both periods. The increase from hospitals that
we owned throughout both periods was attributable to
26
volume increases, primarily from flu and
respiratory cases, rate increases, payor mix and the acuity level of services provided. Our
revenue and volume increases were benefited by one additional business day because the current year
is a leap year partially offset by the Easter holiday occurring prior to March 31, 2008.
On a consolidated basis inpatient admissions increased by 111.1% and adjusted admissions increased
by 102.0%. With respect to consolidated admissions, approximately 52.5% were contributed from
newly acquired hospitals, including those hospitals acquired from Triad, and 47.5% were contributed
by hospitals we owned throughout both periods. On a same-store basis, which includes the hospitals
acquired from Triad, as if we owned them during both periods, admissions increased by 3.8% during
the quarter ended March 31, 2008.
Operating expenses, excluding depreciation and amortization, as a percentage of net operating
revenues, increased to 86.5% for the three months ended March 31, 2008 compared to 85.3% for the
three months ended March 31, 2007. Salaries and benefits, as a percentage of net operating
revenues, decreased 0.2% to 39.9% for the three months ended March 31, 2008, compared to 40.1% for
the three months ended March 31, 2007. This decrease is primarily the result of obtaining
economies of scale from the acquisition of Triad. Provision for bad debts, as a percentage of net
operating revenues, decreased 0.2% to 10.9% for the three months ended March 31, 2008 compared to
11.1% for the three months ended March 31, 2007. This decrease is primarily the result of the
former Triad hospitals having a self-pay discount program and historically lower provision for bad
debts, as well as our phasing in of a discounting program at those hospitals where one previously
did not exist. Supplies, as a percentage of net operating revenues, increased 2.6% to 14.2% for
the three months ended March 31, 2008, as compared to 11.6% for the three months ended March 31,
2007, primarily from the acquisition of the former Triad hospitals whose higher acuity of services
resulted in higher supply costs than our hospitals taken collectively, offsetting improvements from
greater utilization of and improved pricing under our purchasing program. Rent and other operating
expenses, as a percentage of net operating revenues, decreased from 22.5% for the three months
ended March 31, 2007, to 21.5% for the three months ended March 31, 2008. As part of our
acquisition of Triad, we acquired minority investments in certain joint ventures. These
investments provided earnings of 0.5% of net operating revenues. Prior to the Triad acquisition,
we did not have any material investments in unconsolidated subsidiaries.
Depreciation and amortization increased from 4.2% of net operating revenues for the three months
ended March 31, 2007 to 4.5% of net operating revenues for the quarter ended March 31, 2008. The
increase in depreciation and amortization as a percentage of net operating revenue is primarily due
to the acquisition of the former Triad hospitals which, as a result of a higher level of capital
spending, had a depreciable asset base which is higher in relation to its respective revenue than
that of our hospitals in the comparable period.
Interest expense, net, increased by $137.3 million from $28.4 million for the three months ended
March 31, 2007, to $165.7 million for the three months ended March 31, 2008. Since the current
year is a leap year, one additional day in the quarter resulted in $0.4 million of the increase in
interest expense. An increase in interest rates during the three months ended March 31, 2008, as
compared to the three months ended March 31, 2007, accounted for $6.6 million of this increase,
while an increase in our average outstanding debt during the three months ended March 31, 2008, as
compared to the three months ended March 31, 2007, accounted for the remaining $130.3 million.
Income from continuing operations margin decreased from 5.0% for the three months ended March 31,
2007, to 1.9% for the three months ended March 31, 2008. Net income margin decreased from 4.7% for
the three months ended March 31, 2007 to 2.2% for the three months ended March 31, 2008. The
decrease in income from continuing operations margin and net income margin are reflective of the
net increases in operating expenses, depreciation expense and interest expense, as discussed above.
The net results of the above mentioned changes resulted in income from continuing operations before
income taxes decreasing $9.4 million from $93.1 million for the three months ended March 31, 2007
to $83.7 million for the three months ended March 31, 2008.
Provision for income taxes decreased from $35.8 million for the three months ended March 31, 2007
to $32.2 million for the three months ended March 31, 2008, due primarily to a reduction in taxable
income in the comparable periods which was the result of higher operating expenses.
Net income was $60.1 million for the three months ended March 31, 2008 compared to $54.3 million
for the three months ended March 31, 2007, an increase of 10.7%.
27
Liquidity and Capital Resources
Net cash provided by operating activities decreased $111.5 million from $120.3 million for the
three months ended March 31, 2007 to $8.9 million for the three months ended March 31, 2008. The
decrease in cash flow, in comparison to the prior year period is primarily the result of a net cash
outflow from accounts receivable of $66.7 million, reflecting the growth in net operating revenues
and volume, as compared to the same prior year period. As much of this growth occurred in the
latter part of the quarter, the collections of the related cash has not yet occurred as of March
31, 2008. Additionally, there was a decrease in cash flow in comparison to the prior year period
from net cash from accounts payable, accrued liabilities and income taxes of $127.7 million,
primarily reflecting interest payments in excess of interest expense of $62.2 million as a result
of making our first semi-annual interest payment on the Notes in January 2008, a $49.4
million annual payment to the former Triads 401(k) and retirement plan and a pre-funding of $18.0
million of medical claims in 2006 that carried over into the three month period ending March 31,
2007 that did not occur in the three month period ending March 31, 2008. These decreases in cash
were offset by an increase in net income of $5.8 million, an increase in non-cash depreciation
expense of $71.2 million, an increase of other non-cash expenses of $7.9 million and a decrease in
cash from the net activity of all other assets and liabilities of $2.0 million. The cash provided
by investing activities increased to $184.1 million for the three months ended March 31, 2008 from
a use of cash of $95.7 million for the three months ended March 31, 2007. This increase in cash
was due to the sale of 11 hospitals as well as not completing any acquisitions during the three
months ended March 31, 2008, offset by an increase in capital expenditures compared to the three
months ended March 31, 2007. Increase in other assets in investing activities includes $40.1
million of proceeds received from the sale of hospitals and land that has been deposited in escrow
accounts to be used for the acquisition of like-kind property.
Capital Expenditures
Cash expenditures related to purchases of facilities were $1.7 million for the three months ended
March 31, 2008, compared to $44.0 million for the three months ended March 31, 2007. These
expenditures during the three months ended March 31, 2008 were for the acquisition of four
physician practices. The expenditures during the three months ended March 31, 2007, included $40.0
million related to the acquisition of Triad and $4.0 million for the contingent settlements of
working capital items from a prior year acquisition, the acquisition of three physician practices
and the purchase of information systems and other equipment to integrate recently acquired
hospitals.
Excluding the cost to construct replacement hospitals, our capital expenditures for the three
months ended March 31, 2008, totaled $87.5 million, compared to $28.4 million for the three months
ended March 31, 2007. Costs to construct replacement hospitals totaled $49.6 million during the
three months ended March 31, 2008 and $16.4 million during the three months ended March 31, 2007.
Pursuant to hospital purchase agreements in effect as of March 31, 2008, and where required
certificate of need approval has been obtained, we are required to build replacement facilities in
Petersburg, Virginia, by August 2008, Clarksville, Tennessee by June 2009, Shelbyville, Tennessee
by June 2009 and Valparaiso, Indiana by April 2011. Also, as required by an amendment to a lease
agreement entered into in 2005, we agreed to build a replacement hospital at our Barstow,
California location. Estimated construction costs, including equipment, are approximately $643.9
million for these five replacement hospitals of which approximately $300.7 million has been
incurred to date, including costs incurred by Triad prior to our acquisition.
Capital Resources
Net working capital was $1.304 billion at March 31, 2008, compared to $1.105 billion at December
31, 2007. The $199 million increase was attributable primarily to an increase in cash and accounts
receivable and a decrease in accounts payable, which reflects the timing of our cash collections
and payments.
In connection with the consummation of the Triad acquisition in July 2007, we obtained $7.215
billion of senior secured financing under a New Credit Facility with a syndicate of financial
institutions led by Credit Suisse, as administrative agent and collateral agent. The New Credit
Facility consists of a $6.065 billion funded term loan facility with a maturity of seven years, a
$300 million delayed draw term loan facility, (reduced from $400 million) with a maturity of seven
years and a $750 million revolving credit facility with a maturity of six years. The revolving
credit facility also includes a subfacility for letters of credit and a swingline subfacility. The
New Credit Facility requires quarterly amortization payments of each term loan facility
equal to 0.25% of the initial outstanding amount of the term loans, if any, with the outstanding
principal balance of each term loan facility payable on July 25, 2014.
28
The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of
certain asset sales and dispositions by us and our subsidiaries, subject to certain exceptions and
reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or
receivables based financing by us and our subsidiaries, subject to certain exceptions, and (3) 50%,
subject to reduction to a lower percentage based on our leverage ratio (as defined in the New
Credit Facility generally as the ratio of total debt on the date of determination to our EBITDA, as
defined, for the four quarters most recently ended prior to such date), of excess cash flow (as
defined) for any year, commencing in 2008, subject to certain exceptions. Voluntary prepayments
and commitment reductions are permitted in whole or in part, without premium or penalty, subject to
minimum prepayment or reduction requirements.
The obligor under the New Credit Facility is CHS/Community Health Systems, Inc., or CHS, a
wholly-owned subsidiary of Community Health Systems, Inc. All of our obligations under the New
Credit Facility are unconditionally guaranteed by Community Health Systems, Inc. and certain
existing and subsequently acquired or organized domestic subsidiaries. All obligations under the
New Credit Facility and the related guarantees are secured by a perfected first priority lien or
security interest in substantially all of the assets of Community Health Systems, Inc., CHS and
each subsidiary guarantor, including equity interests held by us or any subsidiary guarantor, but
excluding, among others, the equity interests of non-significant subsidiaries, syndication
subsidiaries, securitization subsidiaries and joint venture subsidiaries.
The loans under the New Credit Facility will bear interest on the outstanding unpaid principal
amount at a rate equal to an applicable percentage plus, at our option, either (a) an Alternate
Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined)
announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of
1.0%, or (b) a reserve adjusted London interbank offered rate for dollars (Eurodollar rate (as
defined)). The applicable percentage for term loans is 1.25% for Alternate Base Rate loans and
2.25% for Eurodollar rate loans. The applicable percentage for revolving loans will initially be
1.25% for Alternate Base Rate revolving loans and 2.25% for Eurodollar revolving loans, in each
case subject to reduction based on our leverage ratio. Loans under the swingline subfacility bear
interest at the rate applicable to Alternate Base Rate loans under the revolving credit facility.
We have agreed to pay letter of credit fees equal to the applicable percentage then in effect with
respect to Eurodollar rate loans under the revolving credit facility times the maximum aggregate
amount available to be drawn under all letters of credit outstanding under the subfacility for
letters of credit. The issuer of any letter of credit issued under the subfacility for letters of
credit will also receive a customary fronting fee and other customary processing charges. We are
initially obligated to pay commitment fees of 0.50% per annum (subject to reduction based upon on
our leverage ratio), on the unused portion of the revolving credit facility. For purposes of this
calculation, swingline loans are not treated as usage of the revolving credit facility. We are also
obligated to pay commitment fees of 0.50% per annum for the first six months after the close of the
New Credit Facility, 0.75% per annum for the next three months thereafter and 1.0% per annum
thereafter, in each case on the unused amount of the delayed draw term loan facility. We also paid
arrangement fees on the closing of the New Credit Facility and will pay an annual administrative
agent fee.
The New Credit Facility contains customary representations and warranties, subject to limitations
and exceptions, and customary covenants restricting our and our subsidiaries ability to, among
other things and subject to various exceptions, (1) declare dividends, make distributions or redeem
or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or grant
negative pledges, (4) make loans and investments and enter into acquisitions and joint ventures,
(5) incur additional indebtedness or provide certain guarantees, (6) make capital expenditures, (7)
engage in mergers, acquisitions and asset sales, (8) conduct transactions with affiliates, (9)
alter the nature of our businesses, (10) grant certain guarantees with respect to physician
practices, (11) engage in sale and leaseback transactions or (12) change our fiscal year. We and
our subsidiaries are also required to comply with specified financial covenants (consisting of a
leverage ratio and an interest coverage ratio) and various affirmative covenants.
Events of default under the New Credit Facility include, but are not limited to, (1) our failure to
pay principal, interest, fees or other amounts under the credit agreement when due (taking into
account any applicable grace period), (2) any representation or warranty proving to have been
materially incorrect when made, (3) covenant defaults subject, with respect to certain covenants,
to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6) certain
undischarged judgments (not paid within an applicable grace period), (7) a change of control, (8)
certain ERISA-related defaults, and (9) the invalidity or impairment of specified security
interests, guarantees or subordination provisions in favor of the administrative agent or lenders
under the New Credit Facility.
29
As of March 31, 2008, there was approximately $1.050 billion of available borrowing capacity under
our New Credit Facility, of which $35 million was set aside for outstanding letters of credit. We
believe that these funds, along with internally generated cash and continued access to the bank
credit and capital markets, will be sufficient to finance future acquisitions, capital expenditures
and working capital requirements through the next 12 months and into the foreseeable future.
During the quarter ended March 31, 2008, we repurchased on the open market and cancelled $62.7
million of the Notes. This resulted in a loss from early extinguishment of debt of $1.3 million
with an after-tax impact of $0.9 million.
As of March 31, 2008, we are currently a party to the following interest rate swap agreements to
limit the effect of changes in interest rates on a portion of our long-term borrowings. On each of
these swaps, we received a variable rate of interest based on the three-month London Inter-Bank
Offer Rate (LIBOR), in exchange for the payment by us of a fixed rate of interest. We currently
pay, on a quarterly basis, a margin above LIBOR of 225 basis points for revolving credit and term
loans under the New Credit Facility.
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional |
|
|
|
|
|
|
|
Amount |
|
Fixed Interest |
|
Termination |
|
Swap # |
|
(in 000s) |
|
Rate |
|
Date |
|
1
|
|
|
100,000 |
|
|
|
4.0610 |
% |
|
May 30, 2008 |
|
2
|
|
|
100,000 |
|
|
|
2.4000 |
% |
|
June 13, 2008 |
|
3
|
|
|
100,000 |
|
|
|
3.5860 |
% |
|
August 29, 2008 |
|
4
|
|
|
100,000 |
|
|
|
3.9350 |
% |
|
June 6, 2009 |
|
5
|
|
|
100,000 |
|
|
|
4.3375 |
% |
|
November 30, 2009 |
|
6
|
|
|
100,000 |
|
|
|
4.9360 |
% |
|
October 4, 2010 |
|
7
|
|
|
100,000 |
|
|
|
4.7090 |
% |
|
January 24, 2011 |
|
8
|
|
|
300,000 |
|
|
|
5.1140 |
% |
|
August 8, 2011 |
|
9
|
|
|
100,000 |
|
|
|
4.7185 |
% |
|
August 19, 2011 |
|
10
|
|
|
100,000 |
|
|
|
4.7040 |
% |
|
August 19, 2011 |
|
11
|
|
|
100,000 |
|
|
|
4.6250 |
% |
|
August 19, 2011 |
|
12
|
|
|
200,000 |
|
|
|
4.9300 |
% |
|
August 30, 2011 |
|
13
|
|
|
200,000 |
|
|
|
4.4815 |
% |
|
October 26, 2011 |
|
14
|
|
|
200,000 |
|
|
|
4.0840 |
% |
|
December 3, 2011 |
|
15
|
|
|
100,000 |
|
|
|
3.8470 |
% |
|
January 4, 2012 |
|
16
|
|
|
100,000 |
|
|
|
3.8510 |
% |
|
January 4, 2012 |
|
17
|
|
|
100,000 |
|
|
|
3.8560 |
% |
|
January 4, 2012 |
|
18
|
|
|
200,000 |
|
|
|
3.7260 |
% |
|
January 8, 2012 |
|
19
|
|
|
200,000 |
|
|
|
3.5065 |
% |
|
January 16, 2012 |
|
20
|
|
|
250,000 |
|
|
|
5.0185 |
% |
|
May 30, 2012 |
|
21
|
|
|
150,000 |
|
|
|
5.0250 |
% |
|
May 30, 2012 |
|
22
|
|
|
200,000 |
|
|
|
4.6845 |
% |
|
September 11, 2012 |
|
23
|
|
|
125,000 |
|
|
|
4.3745 |
% |
|
November 23, 2012 |
|
24
|
|
|
75,000 |
|
|
|
4.3800 |
% |
|
November 23, 2012 |
|
25
|
|
|
150,000 |
|
|
|
5.0200 |
% |
|
November 30, 2012 |
|
26
|
|
|
100,000 |
|
|
|
5.0230 |
% |
|
May 30, 2013 |
(1) |
27
|
|
|
300,000 |
|
|
|
5.2420 |
% |
|
August 6, 2013 |
|
28
|
|
|
100,000 |
|
|
|
5.0380 |
% |
|
August 30, 2013 |
(2) |
29
|
|
|
100,000 |
|
|
|
5.0500 |
% |
|
November 30, 2013 |
(3) |
30
|
|
|
100,000 |
|
|
|
5.2310 |
% |
|
July 25, 2014 |
|
31
|
|
|
100,000 |
|
|
|
5.2310 |
% |
|
July 25, 2014 |
|
32
|
|
|
200,000 |
|
|
|
5.1600 |
% |
|
July 25, 2014 |
|
33
|
|
|
75,000 |
|
|
|
5.0405 |
% |
|
July 25, 2014 |
|
34
|
|
|
125,000 |
|
|
|
5.0215 |
% |
|
July 25, 2014 |
|
|
|
|
(1) |
|
This swap agreement becomes effective May 30, 2008, concurrent with the
termination of agreement #1 listed above. |
|
(2) |
|
This swap agreement becomes effective June 13, 2008, concurrent with the
termination of agreement #2 listed above. |
|
(3) |
|
This swap agreement becomes effective September 2, 2008, after the termination
of agreement #3 listed above. |
31
Our swaps that were in effect prior to the Triad acquisition remained in effect after the
refinancing for the Triad acquisition and will continue to be used to limit the effects of changes
in interest rates on portions of our New Credit Facility.
The New Credit Facility and/or the Notes contain various covenants that limit our ability to take
certain actions including, among other things, our ability to:
|
|
|
incur, assume or guarantee additional indebtedness; |
|
|
|
|
issue redeemable stock and preferred stock; |
|
|
|
|
repurchase capital stock; |
|
|
|
|
make restricted payments, including paying dividends and making investments; |
|
|
|
|
redeem debt that is junior in right of payment to the notes; |
|
|
|
|
create liens without securing the notes; |
|
|
|
|
sell or otherwise dispose of assets, including capital stock of subsidiaries; |
|
|
|
|
enter into agreements that restrict dividends from subsidiaries; |
|
|
|
|
merge, consolidate, sell or otherwise dispose of substantial portions of our
assets; |
|
|
|
|
enter into transactions with affiliates; and |
|
|
|
|
guarantee certain obligations. |
In addition, our New Credit Facility contains restrictive covenants and requires us to maintain
specified financial ratios and satisfy other financial condition tests. Our ability to meet these
restricted covenants and financial ratios and tests can be affected by events beyond our control,
and we cannot assure you that we will meet those tests. A breach of any of these covenants could
result in a default under our New Credit Facility and/or the Notes. Upon the occurrence of an event
of default under our New Credit Facility or the Notes, all amounts outstanding under our New Credit
Facility and the Notes may become due and payable and all commitments under the New Credit Facility
to extend further credit may be terminated.
We believe that internally generated cash flows, availability for additional borrowings under our
New Credit Facility of $1.050 billion (consisting of a $750 million revolving credit facility and a
$300 million delayed draw term loan facility) and our ability to add up to $300 million of
borrowing capacity from receivable transactions (including securitizations) and continued access to
the bank credit and capital markets will be sufficient to finance acquisitions, capital
expenditures and working capital requirements through the next 12 months. We believe these same
sources of cash flows, borrowings under our credit agreement as well as access to bank credit and
capital markets will be available to us beyond the next 12 months and into the foreseeable future.
Off-balance sheet arrangements
Excluding the hospitals whose leases terminated in conjunction with our sale of interests in the
partnerships holding the leases and whose operating results are included in discontinued
operations, our consolidated operating results for the three months ended March 31, 2008 and 2007,
included $67.5 million and $67.6 million, respectively, of net operating revenue and $0.1 million
and $4.9 million, respectively, of income from operations, generated from six hospitals operated by
us under operating lease arrangements. In accordance with accounting principles generally accepted
in the United States of America, or GAAP, the respective assets and the future lease obligations
under these arrangements are not recorded on our condensed consolidated balance sheet. Lease
payments under these arrangements are included in rent expense when paid and totaled approximately
$4.1 million for the three months ended March 31, 2008, compared to $3.6 million for the three
months ended March 31, 2007. The current terms of these operating leases expire between June 2010
and December 2019, not including lease extension options. If we allow these leases to expire, we
would no longer generate revenue nor incur expenses from these hospitals.
32
In the past, we have utilized operating leases as a financing tool for obtaining the operations of
specified hospitals without acquiring, through ownership, the related assets of the hospital and
without a significant outlay of cash at the front end of the lease. We utilize the same management
and operating strategies to improve operations at those hospitals held under operating leases as we
do at those hospitals that we own. We have not entered into any operating leases for hospital
operations since December 2000.
Joint Ventures
We have sold minority interests in certain of our subsidiaries or acquired subsidiaries with
existing minority interest ownership positions. The amount of minority interest in equity is
included in other long-term liabilities and the minority interest in income or loss is recorded
separately in the condensed consolidated statements of income. Triad also implemented this
strategy to a greater extent than we did. In conjunction with the acquisition of Triad, we acquired
19 hospitals containing minority ownership interests ranging from less than 1% to 35%. As of March
31, 2008, 19 of our hospitals were owned by physician joint ventures, of which two also had
non-profit entities as partners. In addition, six other hospitals had non-profit entities as
partners. The balance of minority interests was $384.1 million
and $366.1 million as of March 31, 2008 and December 31, 2007, respectively, and the amount of
minority interest in earnings was $9.7 million and $0.2 million for the three months ended March
31, 2008 and 2007, respectively.
Reimbursement, Legislative and Regulatory Changes
Legislative and regulatory action has resulted in continuing change in the Medicare and Medicaid
reimbursement programs which will continue to limit payment increases under these programs and in
some cases implement payment decreases. Within the statutory framework of the Medicare and
Medicaid programs, there are substantial areas subject to administrative rulings, interpretations,
and discretion which may further affect payments made under those programs, and the federal and
state governments might, in the future, reduce the funds available under those programs or require
more stringent utilization and quality reviews of hospital facilities. Additionally, there may be a
continued rise in managed care programs and future restructuring of the financing and delivery of
healthcare in the United States. These events could cause our future financial results to decline.
Inflation
The healthcare industry is labor intensive. Wages and other expenses increase during periods of
inflation and when labor shortages occur in the marketplace. In addition, our suppliers pass along
rising costs to us in the form of higher prices. We have implemented cost control measures,
including our case and resource management program, to curb increases in operating costs and
expenses. We have generally offset increases in operating costs by increasing reimbursement for
services, expanding services and reducing costs in other areas. However, we cannot predict our
ability to cover or offset future cost increases.
Critical Accounting Policies
The discussion and analysis of our financial condition and results of operations are based upon our
condensed consolidated financial statements, which have been prepared in accordance with GAAP. The
preparation of these financial statements requires us to make estimates and judgments that affect
the reported amount of assets and liabilities, revenues and expenses, and related disclosure of
contingent assets and liabilities at the date of our condensed consolidated financial statements.
Actual results may differ from these estimates under different assumptions or conditions.
Critical accounting policies are defined as those that are reflective of significant judgments and
uncertainties, and potentially result in materially different results under different assumptions
and conditions. We believe that our critical accounting policies are limited to those described
below.
Third Party Reimbursement
Net operating revenues include amounts estimated by management to be reimbursable by Medicare and
Medicaid under prospective payment systems and provisions of cost-reimbursement and other payment
methods. In addition, we are reimbursed by non-governmental payors using a variety of payment
methodologies. Amounts we receive for treatment of patients covered by these programs are generally
less than the standard billing rates. Excluding the former
33
Triad hospitals, contractual allowances
are automatically calculated and recorded through our internally developed automated contractual
allowance system. Within the automated system, actual Medicare DRG data, coupled with all payors
historical paid claims data, is utilized to calculate the contractual allowances. This data is
automatically updated on a monthly basis. For the former Triad hospitals, contractual allowances
are determined through a manual process wherein contractual allowance adjustments, regardless of
payor or method of calculation, are reviewed and compared to actual payment experience. The
methodology used is similar to the methodology used within our automated contractual allowance
system. The former Triad hospitals are being phased into the automated contractual allowance
system. All hospital contractual allowance calculations are subjected to monthly review by
management to ensure reasonableness and accuracy. We account for the differences between the
estimated program reimbursement rates and the standard billing rates as contractual allowance
adjustments, which we deduct from gross revenues to arrive at net operating revenues. Final
settlements under some of these programs are subject to adjustment based on administrative review
and audit by third parties. We record adjustments to the estimated billings in the periods that
such adjustments become known. We account for adjustments to previous program reimbursement
estimates as contractual allowance adjustments and report them in future periods as final
settlements are determined. However, due to the complexities involved in these estimates, actual
payments we receive could be different from the amounts we estimate and record. Contractual
allowance adjustments related to final settlements or appeals increased net operating revenue by an
insignificant amount in each of the three month periods ended March 31, 2008 and March 31, 2007.
Allowance for Doubtful Accounts
Substantially all of our accounts receivable are related to providing healthcare services to our
hospitals patients. Collection of these accounts receivable is our primary source of cash and is
critical to our operating performance. Our primary collection risks relate to uninsured patients
and outstanding patient balances for which the primary insurance payor has paid some but not all of
the outstanding balance, with the remaining outstanding balance (generally deductibles and
co-payments) owed by the patient. At the point of service, for patients required to make a
co-payment, we generally collect less than 15% of the related revenue. For all procedures scheduled
in advance, our policy is to verify insurance coverage prior to the date of the procedure.
Insurance coverage is not verified in advance of procedures for walk-in and emergency room
patients.
We estimate the allowance for doubtful accounts by reserving a percentage of all self-pay accounts
receivable without regard to aging category, based on collection history, adjusted for expected
recoveries and, if present, anticipated changes in trends. For all other payor categories we
reserve 100% of all accounts aging over 365 days from the date of discharge. The percentage used to
reserve for all self-pay accounts is based on our collection history. We believe that we collect
substantially all of our third-party insured receivables which include receivables from
governmental agencies. During the quarter ended December 31, 2007, in conjunction with our ongoing
process of monitoring the net realizable value of our accounts receivable, as well as integrating
the methodologies, data and assumptions used by the former Triad management, we performed various
analyses including updating a review of historical cash collections. As a result of these analyses,
we noted deterioration in certain key cash collection indicators. The acquisition of Triad also
provided additional data and a comparative and larger population on which to base our estimates. As
a result of the lower estimated collectability indicated by the updated analyses, we recorded an
increase to our contractual reserves of $96.3 million and an increase to our allowance for doubtful
accounts of approximately $70.1 million as of December 31, 2007. The resulting impact, net of
taxes, for the year ended December 31, 2007 was a decrease to income from continuing operations of
$105.4 million. We believe this lower collectability was primarily the result of an increase in the
number of patients qualifying for charity care, reduced enrollment in certain state Medicaid
programs and an increase in the number of indigent non-resident aliens. Collections are impacted by
the economic ability of patients to pay and the effectiveness of our collection efforts.
Significant changes in payor mix, business office operations, economic conditions or trends in
federal and state governmental healthcare coverage could affect our collection of accounts
receivable. We also continually review our overall reserve adequacy by monitoring historical cash
collections as a percentage of trailing net revenue less provision for bad debts, as well as by
analyzing current period net revenue and admissions by payor classification, aged accounts
receivable by payor, days revenue outstanding, and the impact of recent acquisitions and
dispositions.
Our policy is to write-off gross accounts receivable if the balance is under $10.00 or when such
amounts are placed with outside collection agencies. We believe this policy accurately reflects
the ongoing collection efforts within the Company and is consistent with industry practices. We
had approximately $1.5 billion at March 31, 2008 and December 31, 2007, being pursued by various
outside collection agencies. We expect to collect less than 3%, net of estimated collection fees,
of the amounts being pursued by outside collection agencies. As these amounts have been
written-off, they are not included in our gross accounts receivable or our allowance for doubtful
accounts. Collections on amounts previously written-off are recognized in income when received.
However, we take into consideration
34
estimated collections of these future amounts written-off in
evaluating the reasonableness of our allowance for doubtful accounts.
Patient accounts receivable from our hospital segment represent approximately 96% of our total
consolidated accounts receivable. Therefore, all of the following information represents that
derived from our hospital segment.
Days revenue outstanding was 54 days at March 31, 2008 and December 31, 2007. Our target range for
days revenue outstanding is 52 58 days.
Total gross accounts receivable (prior to allowance for contractual adjustments and doubtful
accounts) was approximately $5.036 billion as of March 31,
2008 and approximately $4.544 billion as
of December 31, 2007. The approximate percentage of total gross accounts receivable (prior to
allowance for contractual adjustments and doubtful accounts) summarized by aging categories is as
follows:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
March 31, |
|
December 31, |
|
|
2008 |
|
2007 |
0 to 60 days |
|
|
65.7 |
% |
|
|
62.7 |
% |
61 to 150 days |
|
|
16.3 |
% |
|
|
18.4 |
% |
151 to 360 days |
|
|
14.3 |
% |
|
|
14.6 |
% |
Over 360 days |
|
|
3.7 |
% |
|
|
4.3 |
% |
|
|
|
|
|
|
|
|
|
Total |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
The approximate percentage of total gross accounts receivable (prior to allowances for contractual
adjustments and doubtful accounts) summarized by payor category is as follows:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
March 31, |
|
December 31, |
|
|
2008 |
|
2007 |
Insured receivables |
|
|
71.7 |
% |
|
|
69.7 |
% |
Self-pay receivables |
|
|
28.3 |
% |
|
|
30.3 |
% |
|
|
|
|
|
|
|
|
|
Total |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
On a combined basis, as a percentage of gross self-pay receivables, the combined total allowance
for doubtful accounts and related
allowances for other self-pay discounts and contractuals, was approximately 82% at March 31, 2008
and December 31, 2007.
Goodwill and Other Intangibles
Goodwill represents the excess of cost over the fair value of net assets acquired. Goodwill
arising from business combinations is accounted for under the provisions of SFAS No. 141 Business
Combinations and SFAS No. 142 Goodwill and Other Intangible Assets and is not amortized. SFAS
No. 142 requires goodwill to be evaluated for impairment at the same time every year and when an
event occurs or circumstances change such that it is reasonably possible that an impairment may
exist. We selected September 30th as our annual testing date.
The SFAS No. 142 goodwill impairment model requires a comparison of the book value of net assets to
the fair value of the related operations that have goodwill assigned to them. If the fair value is
determined to be less than book value, a second step is performed to compute the amount of the
impairment. We estimated the fair values of the related operations using both a debt free
discounted cash flow model as well as an adjusted EBITDA multiple model. These models are both
based on our best estimate of future revenues and operating costs and are reconciled to our
consolidated market capitalization. The cash flow forecasts are adjusted by an appropriate
discount rate based on our weighted-average cost of capital. We performed our initial evaluation,
as required by SFAS No. 142, during the first quarter of 2002 and the annual evaluation as of each
succeeding September 30. No impairment has been indicated by these evaluations. Estimates used to
conduct the impairment review, including revenue and profitability projections or fair values,
could cause our analysis to indicate that our goodwill is impaired in subsequent periods and result
in a write-off of a portion or all of our goodwill.
35
Impairment or Disposal of Long-Lived Assets
In accordance with SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets,
whenever events or changes in circumstances indicate that the carrying values of certain long-lived
assets may be impaired, we project the undiscounted cash flows expected to be generated by these
assets. If the projections indicate that the reported amounts are not expected to be recovered,
such amounts are reduced to their estimated fair value based on a quoted market price, if
available, or an estimate based on valuation techniques available in the circumstances.
Professional Liability Insurance Claims
We accrue for estimated losses resulting from professional liability claims. The accrual, which
includes an estimate for incurred but not reported claims, is based on historical loss patterns and
actuarially determined projections and is discounted to its net present value using a weighted
average risk-free discount rate of 4.1% and 4.6% in 2007 and 2006,
respectively. To the extent that subsequent claims information varies from managements estimates,
the liability is adjusted currently. Our insurance is underwritten on a claims-made basis. Prior
to June 1, 2002, substantially all of our professional and general liability risks were subject to
a $0.5 million per occurrence deductible; for claims reported from June 1, 2002 through June 1,
2003, these deductibles were $2.0 million per occurrence. Additional coverage above these
deductibles was purchased through captive insurance companies in which we had a 7.5% minority
ownership interest in each and to which the premiums paid by us represented less than 8% of the
total premium revenues of each captive insurance company. With the formation of our own
wholly-owned captive insurance company in June 2003, we terminated our minority interest
relationships in those entities. Substantially all claims reported after June 1, 2003 and before
June 1, 2005 are self-insured up to $4 million per claim. Substantially all claims reported on or
after June 1, 2005 are self-insured up to $5 million per claim. Management on occasion has
selectively increased the insured risk at certain hospitals based upon insurance pricing and other
factors and may continue that practice in the future. Excess insurance for all hospitals was
purchased through commercial insurance companies and generally covers us for liabilities in excess
of the self-insured amount and up to $100 million per occurrence for claims reported on or after
June 1, 2003.
Effective
January 1, 2008, the former Triad Hospitals are insured on a
claims-made basis through a
policy purchased through our wholly-owned captive insurance company and commercial insurance
companies as described above for substantially all claims occurring on or after January 1, 2007 and
reported on or after January 1, 2008. Substantially all losses for the former Triad hospitals in
periods prior to May 1999 were insured through a wholly-owned insurance subsidiary of HCA, Inc., or
HCA, Triads owner prior to that time, and excess loss policies maintained by HCA. HCA has agreed
to indemnify the former Triad hospitals in respect of claims covered by such insurance policies
arising prior to May 1999. After May 1999 through December 31, 2006, the former Triad hospitals
obtained insurance coverage on a claims incurred basis from HCAs wholly-owned insurance subsidiary
with excess coverage obtained from other carriers that is subject to certain deductibles. Effective
for claims incurred after December 31, 2006, Triad began insuring its claims from $1 million to $5
million through its wholly-owned captive insurance company, replacing the coverage provided by HCA.
Substantially all claims reported during 2007 were self insured up to $10 million per claim.
Income Taxes
We must make estimates in recording provision for income taxes, including determination of deferred
tax assets and deferred tax liabilities and any valuation allowances that might be required against
the deferred tax assets. We believe that future income will enable us to realize these deferred tax
assets, subject to the valuation allowance we have established.
On January 1, 2007, we adopted the provisions of FASB Interpretation No. 48, Accounting for
Uncertainty in Income Taxes (FIN 48). The total amount of unrecognized benefit that would
affect the effective tax rate, if recognized, is approximately $5.9 million as of March 31, 2008.
It is our policy to recognize interest and penalties accrued related to unrecognized benefits in
our condensed consolidated statements of income as income tax expense. During the three months ended March
31, 2008, we recorded approximately $0.2 million in interest and penalties related to prior state
income tax returns through our income tax provision from continuing operations and which are
included in our FIN 48 liability at March 31, 2008. A total of approximately $1.9 million of
interest and penalties is included in the amount of FIN 48 liability at March 31, 2008.
36
Our unrecognized tax benefits consist primarily of state exposure items. We believe it is
reasonably possible that approximately $1.2 million of our current unrecognized tax benefit may
decrease within the next twelve months as a result of a lapse of the statute of limitations and
settlements with taxing authorities.
We or one of our subsidiaries file income tax returns in the U.S. federal jurisdiction and various
state jurisdictions. With few exceptions, we are no longer subject to U.S. federal or state income
tax examinations for years prior to 2003.
The IRS has concluded an examination of the federal income tax returns of Triad for the short
taxable years ended April 27, 2001, June 30, 2001 and December 31, 2001, and the taxable years
ended December 31, 2002 and 2003. We have received a closing letter with
respect to the examination for those tax years. The settlement was
not material to our consolidated results of
operations or consolidated financial position.
Recent Accounting Pronouncements
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and
Financial Liabilities Including an Amendment of FASB Statement No. 115 (SFAS No. 159). SFAS
No. 159 expands the use of fair value accounting but does not affect existing standards that
require assets or liabilities to be carried at fair value. SFAS No. 159 permits an entity, on a
contract-by-contract basis, to make an irrevocable election to account for certain types of
financial instruments and warranty and insurance contracts at fair value, rather than historical
cost, with changes in the fair value, whether realized or unrealized, recognized in earnings. SFAS
No. 159 is effective for fiscal years beginning after November 15, 2007. We adopted SFAS No. 159 as
of January 1, 2008. The adoption of this statement has not had a material effect on our
consolidated results of operations or consolidated financial position.
In December 2007, the FASB issued SFAS No. 141(R), Business Combinations (SFAS No. 141(R)).
SFAS No. 141(R) replaces SFAS No. 141 and addresses the recognition and accounting for identifiable
assets acquired, liabilities assumed, and noncontrolling interests in business combinations. This
standard will require more assets and liabilities be recorded at fair value and will require
expense recognition (rather than capitalization) of certain pre-acquisition costs. This standard
will also require any adjustments to acquired deferred tax assets and liabilities occurring after
the related allocation period to be made through earnings. Furthermore, this standard requires this
treatment of acquired deferred tax assets and liabilities also be applied to acquisitions occurring
prior to the effective date of this standard. SFAS No. 141(R) is effective for fiscal years
beginning after December 15, 2008 and is required to be adopted prospectively with no early
adoption permitted. We will begin applying SFAS No. 141(R) in the first quarter of 2009. We are
currently assessing the potential impact that SFAS No. 141(R) will have on our consolidated results
of operations and financial position.
In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial
Statements (SFAS No. 160). SFAS No. 160 addresses the accounting and reporting framework for
noncontrolling ownership interests in consolidated subsidiaries of the parent. SFAS No. 160 also
establishes disclosure requirements that clearly identify and distinguish between the interests of
the parent company and the interests of the noncontrolling owners and that require minority
ownership interests to be presented separately within equity in the consolidated financial
statements. SFAS No. 160 is effective for fiscal years beginning after December 15, 2008, and will
be adopted by us in the first quarter of 2009. We are currently assessing the potential impact that
SFAS No. 160 will have on our consolidated results of operations and consolidated financial
position.
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging
Activities (SFAS No. 161). SFAS No. 161 expands the disclosure requirements for derivative
instruments and for hedging activities in order to provide additional understanding of how an
entity uses derivative instruments and how they are accounted for and reported in an entitys
financial statements. The new disclosure requirements for SFAS No. 161
37
are effective for fiscal years beginning after November 15, 2008, and will be adopted by us in the first quarter of 2009.
FORWARD-LOOKING STATEMENTS
Some of the matters discussed in this report include forward-looking statements. Statements that
are predictive in nature, that depend upon or refer to future events or conditions or that include
words such as expects, anticipates, intends, plans, believes, estimates,
thinks, and similar expressions are forward-looking statements. These statements involve known
and unknown risks, uncertainties, and other factors that may cause our actual results and
performance to be materially different from any future results or performance expressed or implied
by these forward-looking statements. These factors include, but are not limited to, the following:
|
|
|
general economic and business conditions, both nationally and in the regions in which we
operate; |
|
|
|
|
our ability to successfully integrate any acquisitions or to recognize expected
synergies from such acquisitions, including facilities acquired from Triad; |
|
|
|
|
risks associated with our substantial indebtedness, leverage and debt service
obligations; |
|
|
|
|
demographic changes; |
|
|
|
|
existing governmental regulations and changes in, or the failure to comply with,
governmental regulations; |
|
|
|
|
legislative proposals for healthcare reform; |
|
|
|
|
the impact of the Medicare Prescription Drug, Improvement and Modernization Act of 2003,
which includes specific reimbursement changes for small urban and non-urban hospitals; |
|
|
|
|
potential adverse impact of known and unknown government investigations; |
|
|
|
|
our ability, where appropriate, to enter into managed care provider arrangements and the
terms of these arrangements; |
|
|
|
|
changes in inpatient or outpatient Medicare and Medicaid payment levels; |
|
|
|
|
increases in the amount and risk of collectability of patient accounts receivable |
|
|
|
|
increases in wages as a result of inflation or competition for highly technical
positions and rising supply cost due to market pressure from pharmaceutical companies and
new product releases; |
|
|
|
|
liabilities and other claims asserted against us, including self-insured malpractice
claims; |
|
|
|
|
competition; |
|
|
|
|
our ability to attract and retain without significant employment costs, qualified
personnel, key management, physicians, nurses, and other healthcare workers; |
|
|
|
|
trends toward treatment of patients in less acute or specialty healthcare settings
including ambulatory surgery centers or specialty hospitals; |
|
|
|
|
changes in medical or other technology; |
|
|
|
|
changes in GAAP; |
|
|
|
|
the availability and terms of capital to fund additional acquisitions or replacement
facilities; |
|
|
|
|
our ability to successfully acquire additional hospitals and complete the sale of
hospitals held for sale; |
|
|
|
|
our ability to obtain adequate levels of general and professional liability insurance;
and |
|
|
|
|
timeliness of reimbursement payments received under
government programs. |
Although we believe that these statements are based upon reasonable assumptions, we can give no
assurance that our goals will be achieved. Given these uncertainties, prospective investors are
cautioned not to place undue reliance on these forward-looking statements. These forward-looking
statements are made as of the date of this filing. We assume no obligation to update or revise them
or provide reasons why actual results may differ.
Item 3: Quantitative and Qualitative Disclosures about Market Risk
We are exposed to interest rate changes, primarily as a result of our senior secured credit
facility which bears interest based on floating rates. In order to manage the volatility relating
to the market risk, we entered into interest rate swap agreements described under the heading
Liquidity and Capital Resources in Item 2. We do not anticipate any material changes in our
primary market risk exposures in 2008. We utilize risk management procedures and controls in
executing derivative financial instrument transactions. We do not execute transactions or hold
derivative financial instruments for trading purposes. Derivative financial instruments related to
interest rate sensitivity of debt obligations are used with the goal of mitigating a portion of the
exposure when it is cost effective to do so.
38
A 1% change in interest rates on variable rate debt in excess of that amount covered by interest
rate swaps would have resulted in interest expense fluctuating approximately $3.7 million for the
three months ended March 31, 2008 and $1.1 million for the three months ended March 31, 2007.
Item 4: Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer, with the participation of other members of
management, have evaluated the effectiveness of our disclosure controls and procedures (as defined
in Rules 13a 15(e) and 15d 15(e) under the Securities and Exchange Act of 1934, as amended), as
of December 31, 2007. Based on such evaluations, our Chief Executive Officer and Chief Financial
Officer concluded that, as of such date, our disclosure controls and procedures were effective (at
the reasonable assurance level) to ensure that the information required to be included in this
report has been recorded, processed, summarized and reported within the time periods specified in
the Commissions rules and forms and to ensure that the information required to be included in this
report was accumulated and communicated to management, including our Chief Executive Officer and
Chief Financial Officer, to allow timely decisions regarding required disclosure.
As a result of the completion of the acquisition of Triad on July 25, 2007, our internal controls
over financial reporting have changed. Since the Triad acquisition, we have started to analyze the
systems of disclosure controls
and procedures and internal controls over financial reporting of the former Triad hospitals and
other operations acquired in the Triad acquisition and integrate them within our broader framework
of controls. The Securities and Exchange Commissions rules require us to complete this process by
the first anniversary of the acquisition. We plan to complete this evaluation and integration
within the required time frame and report any changes in internal controls in our first annual
report in which our assessment of the former Triad hospitals and other operations is to be
included. Although we have not yet identified any material weaknesses in our disclosure controls
and procedures or internal control over financial reporting as a result of this acquisition, there
can be no assurance that a material weakness will not be identified in the course of this review.
There have been no changes in our internal control over financial reporting during the quarter
ended March 31, 2008, that have materially affected or are reasonably likely to materially affect,
our internal controls over financial reporting.
39
PART II OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, we receive various inquiries or subpoenas from state regulators, fiscal
intermediaries, the Centers for Medicare and Medicaid Services and the Department of Justice
regarding various Medicare and Medicaid issues. In addition, we are subject to other claims and
lawsuits arising in the ordinary course of our business. We are not aware of any pending or
threatened litigation that is not covered by insurance policies or reserved for in our financial
statements or which we believe would have a material adverse impact on us; however, some pending or
threatened proceedings against us may involve potentially substantial amounts as well as the
possibility of civil, criminal, or administrative fines, penalties, or other sanctions, which could
be material. Settlements of suits involving Medicare and Medicaid issues routinely require both
monetary payments as well as corporate integrity agreements. Additionally, qui tam or
whistleblower actions initiated under the civil False Claims Act may be pending but placed under
seal by the court to comply with the False Claims Acts requirements for filing such suits.
Community Health Systems, Inc. Legal Proceedings
In May 1999, we were served with a complaint in U.S. ex rel. Bledsoe v. Community Health Systems,
Inc., subsequently moved to the Middle District of Tennessee, Case No. 2-00-0083. This qui tam
action sought treble damages and penalties under the False Claims Act against us. The Department of
Justice did not intervene in this action. The allegations in the amended complaint were extremely
general, but involved Medicare billing at our White County Community Hospital in Sparta, Tennessee.
By order entered on September 19, 2001, the U.S. District Court granted our motion for judgment on
the pleadings and dismissed the case, with prejudice. The qui tam whistleblower (also referred to
as a relator) appealed the district courts ruling to the U.S. Court of Appeals for the Sixth
Circuit. On September 10, 2003, the Sixth Circuit Court of Appeals rendered its decision in this
case, affirming in part and reversing in part the district courts decision to dismiss the case
with prejudice. The court affirmed the lower courts dismissal of certain of plaintiffs claims on
the grounds that his allegations had been previously publicly disclosed. In addition, the appeals
court agreed that, as to all other allegations, the relator had failed to include enough
information to meet the special pleading requirements for fraud under the False Claims Act and the
Federal Rules of Civil Procedure. However, the case was returned to the district court to allow the
relator another opportunity to amend his complaint in an attempt to plead his fraud allegations
with particularity. In May 2004, the relator in U.S. ex rel. Bledsoe filed an amended complaint
alleging fraud involving Medicare billing at White County Community Hospital. We then filed a
renewed motion to dismiss the amended complaint. On January 6, 2005, the District Court dismissed
with prejudice the bulk of the relators allegations. The only remaining allegations involve a
small number of 1997-98 charges at White County. After further motion practice between the relator
and the United States Government regarding the relators right to participate in a previous
settlement with the Company, the District Court again dismissed all claims in the case on December
13, 2005. On January 9, 2006, the relator filed a notice of appeal to the U.S. Court of Appeals
for the Sixth Circuit and on September 6, 2007, the Court of Appeals issued its 25 page opinion
affirming in part, reversing in part (and in doing so, reinstating a number of the allegations
claimed by the relator), and remanding the case to the District Court for further proceedings. The
relator has filed a motion for rehearing. That motion for rehearing was denied. We will continue
to vigorously defend this case
In August 2004, we were served a complaint in Arleana Lawrence and Robert Hollins v. Lakeview
Community Hospital and Community Health Systems, Inc. (now styled Arleana Lawrence and Lisa Nichols
vs. Eufaula Community Hospital, Community Health Systems, Inc., South Baldwin Regional Medical
Center and Community Health Systems Professional Services Corporation) in the Circuit Court of
Barbour County, Alabama (Eufaula Division). This alleged class action was brought by the plaintiffs
on behalf of themselves and as the representatives of similarly situated uninsured individuals who
were treated at our Lakeview Hospital or any of our other Alabama hospitals. The plaintiffs allege
that uninsured patients who do not qualify for Medicaid, Medicare or charity care are charged
unreasonably high rates for services and materials and that we use unconscionable methods to
collect bills. The plaintiffs seek restitution of overpayment, compensatory and other allowable
damages and injunctive relief. In October 2005, the complaint was amended to eliminate one of the
named plaintiffs and to add our management company subsidiary as a defendant. In November 2005,
the complaint was again amended to add another plaintiff, Lisa Nichols and another defendant, our
hospital in Foley, Alabama, South Baldwin Regional Medical Center. After a hearing held on June
13, 2007, on October 29, 2007 the Circuit Court ruled in favor of the plaintiffs class action
certification request. We disagree with that ruling and have pursued our automatic right of appeal
to the Alabama Supreme Court. We are vigorously defending this case.
40
On March 3, 2005, we were served with a complaint in Sheri Rix v. Heartland Regional Medical Center
and Health Care Systems, Inc. in the Circuit Court of Williamson County, Illinois. This alleged
class action was brought by the plaintiff on behalf of herself and as the representative of
similarly situated uninsured individuals who were treated at our Heartland Regional Medical Center.
The plaintiff alleges that uninsured patients who do not qualify for Medicaid, Medicare or charity
care are charged unreasonably high rates for services and materials and that we use unconscionable
methods to collect bills. The plaintiff seeks recovery for breach of contract and the covenant of
good faith and fair dealing, violation of the Illinois Consumer Fraud and Deceptive Practices Act,
restitution of overpayment, and for unjust enrichment. The plaintiff class seeks compensatory and
other damages and equitable relief. The Circuit Court Judge recently granted our motion to dismiss
the case, but allowed the plaintiff to re-plead her case. The plaintiff elected to appeal the
Circuit Courts decision in lieu of amending her case. Oral argument was heard on this case on
January 9, 2008 and we await the ruling of the District Appellate Court. We are vigorously
defending this case.
On April 8, 2005, we were served with a first amended complaint, styled Chronister, et al. v.
Granite City Illinois Hospital Company, LLC d/b/a Gateway Regional Medical Center, in the Circuit
Court of Madison County, Illinois. The complaint seeks class action status on behalf of the
uninsured patients treated at Gateway Regional Medical Center and alleges statutory, common law,
and consumer fraud in the manner in which the hospital bills and collects for the services rendered
to uninsured patients. The plaintiff seeks compensatory and punitive damages and declaratory and
injunctive relief. Our motion to dismiss has been granted in part and denied in part and discovery
has commenced. Gateway Regional Medical Center v. Holman is a companion case to the Chronister
action, seeking counterclaim recovery on a collections case. Holman has been stayed pending the
outcome of the Chronister action. We are vigorously defending these cases.
On February 10, 2006, we received a letter from the Civil Division of the Department of Justice
requesting documents in an investigation they are conducting involving the Company. The inquiry
relates to the way in which different state Medicaid programs apply to the federal government for
matching or supplemental funds that are ultimately used to pay for a small portion of the services
provided to Medicaid and indigent patients. These programs are referred to by different names,
including intergovernmental payments, upper payment limit programs, and Medicaid
disproportionate share hospital payments. The February 10th letter focused on our hospitals in 3
states: Arkansas, New Mexico, and South Carolina. On August 31, 2006, we received a follow up
letter from the Department of Justice requesting additional documents relating to the programs in
New Mexico and the payments to the Companys three hospitals in that state. We have provided the
Department of Justice with the requested documents. In a letter dated October 4, 2007, the Civil
Division notified us that, based on its investigation to date, it preliminarily believes that we
and these three New Mexico hospitals have caused the State of New Mexico to submit improper claims
for federal funds, in violation of the Civil False Claims Act. The DOJ asserted that these
allegedly improper claims and payments began in 2000 and may be ongoing, but provided no
information about the amount of any improper claims or the possible damages or penalties it may
seek. After a meeting between us and the DOJ held in November 2007, by letter dated January 22,
2008, the Civil Division notified us that they continued to believe that the False Claims Act had
been violated and had calculated that the three hospitals received ineligible federal participation
payments from August 2000 to June 2006 of approximately $27.5 million. The Civil Division advised
us that if they proceeded to trial, they would seek treble damages plus an appropriate penalty for
each of the violations of the False Claims Act. Discussions are continuing with the Civil Division
in an effort to resolve this matter. The Company continues to believe that it has not violated the
Federal False Claims Act in the manner described in the governments letter of January 22, 2008.
In August 2006, our facility in Petersburg, Virginia (Southside Regional Medical Center) was
notified of the pendency of a federal False Claims Act case styled U.S. ex rel. Vuyyuru v. Jadhav
et al. filed in the Eastern District of Virginia. In addition to naming the hospital, Community
Health Systems Professional Services Corporation, our management subsidiary, has also been named.
The suit alleges that Dr. Jadhav, Southside Regional Medical Center, and other healthcare providers
performed medically unnecessary procedures and billed federal healthcare programs and also alleges
that the defendants defamed Dr. Vuyyuru in the process of terminating his medical staff privileges.
Almost all of the allegations pre-date our acquisition of this facility and the sellers
successor-in-interest has agreed to indemnify the Company and its affiliates. We believe that the
allegations in this case are without merit and are vigorously defending the case. A motion to
dismiss the case has been granted and the relator has appealed the ruling to the U.S. Court of
Appeals for the Fourth Circuit.
On August 28, 2007, Texas Health Resources of Arlington, Texas, or THR, notified us of its decision
to exercise a call right to acquire our 80% interest in the limited partnership that owns
Presbyterian Hospital of Denton, Texas, together with certain land and buildings that we own in
Denton (including rights under a lease for such land and
41
buildings). We acquired these interests in connection with the Triad acquisition. This call right
became exercisable under the terms of the limited partnership agreement by reasons of our
acquisition of Triad. Shortly after we initiated efforts to set the purchase price, which is
determined by various formulas set forth in the limited partnership agreement and related
documents, THR filed suit in Texas state court seeking injunctive and declaratory relief to extend
the 90-day closing date and to set the purchase price. We removed the case to Federal District
Court and proceedings are underway in that court with respect to THRs renewed motions for relief.
Pursuant to the limited partnership agreement, the closing was to occur on or before November 26,
2007. The closing did not occur on November 26, 2007, as THR failed to properly tender adequate
closing consideration. The case will proceed and the pre-trial and trial scheduling conference is
set for September 8, 2008.
Triad Hospitals, Inc. Legal Proceedings
Triad, and its subsidiary, Quorum Health Resources, Inc. are defendants in a qui tam case styled
U.S. ex rel. Whitten vs. Quorum Health Resources, Inc. et al., which is pending in the Southern
District of Georgia, Brunswick Division. Whitten, a long-term employee of a two hospital system in
Brunswick and Camden, Georgia sued both his employer and Quorum Health Resources, Inc. and its
predecessors, which had managed the facility from 1989 through September 2000; upon his termination
of employment, Whitten signed a release and was paid $124,000. Whittens original qui tam
complaint was filed under seal in November 2002 and the case was unsealed in 2004. Whitten alleges
various charging and billing infractions, including charging for routine equipment supplies and
services not separately billable, billing for observation services that were not medically
necessary or for which there was no physician order, billing labor and delivery patients for
durable medical equipment that was not separately billable, inappropriate preparation of patients
histories and physicals, billing for cardiac rehabilitation services without physician supervision,
performing outpatient dialysis without Medicare certification, and performing mental health
services without the proper staff assignments. In October 2005, the district court granted
Quorums motion for summary judgment on the grounds that his claims were precluded under his
severance agreement with the hospital, without reaching two other arguments made by Quorum, which
included that a prior settlement agreement between the hospital and the federal government
precluded the claims brought by Whitten as well as the doctrine of prior public disclosure. On
appeal to the 11th Circuit Court of Appeals, the court reversed the findings of the district court
regarding the severance agreement, but remanded the case to the district court for findings on
Quorums other two defenses. Limited discovery has been conducted and renewed motions by Quorum to
dismiss the action and to stay further discovery were filed in September 2007. We await the
district courts ruling on our motion to dismiss. We continue to believe that the relators claims
are without merit and will continue to vigorously defend this case.
In a case styled U.S. ex rel. Bartlett vs. Quorum Health Resources, Inc., et al., pending in the
Western District of Pennsylvania, Johnstown Division, the relator alleges in his second amended
complaint, filed in January 2006 (the first amended complaint having been dismissed), that Quorum
conspired with an unaffiliated hospital to pay a illegal remuneration in violation of the
anti-kickback statute and the Stark laws, thus causing false claims to be filed. A renewed motion
to dismiss that was filed in March 2006 asserting that the second amended complaint did not cure
the defects contained in the first amended complaint. In September 2006, the hospital and one of
the other defendants affiliated with the hospital filed for protection under Chapter 11 of the
federal bankruptcy code, which imposed an automatic stay on proceedings in the case. We believe
that this case is without merit and should the stay be lifted, will continue to vigorously defend
it.
Item 1A.Risk Factors
There have been no material changes with regard to risk factors previously disclosed in our most
recent annual report on Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On December 13, 2006, the Company commenced an open market repurchase program for up to 5,000,000
shares of the Companys common stock not to exceed $200 million in purchases. This purchase
program will conclude at the earlier of three years or when the maximum number of shares have been
repurchased. As of March 31, 2008, the Company has not repurchased any shares under this program.
We have not paid any cash dividends since our inception, and do not anticipate the payment of cash
dividends in the foreseeable future. Our New Credit Facility limits our ability to pay dividends
and/or repurchase stock to an amount not to exceed $400 million in the aggregate (but not in excess
of $200 million unless we receive confirmation from Moodys and S&P that dividends or repurchases
would not result in a downgrade, qualification or withdrawal of the
42
then corporate credit rating). The indenture governing our Notes also limits our ability to pay
dividends and/or repurchase stock. As of March 31, 2008, the amount of permitted dividends and/or
stock repurchases permitted under the indenture was $392 million.
Item 3. Defaults Upon Senior Securities
None
Item 4. Submission of Matters to a Vote of Security Holders
None
Item 5. Other Information
None
Item 6. Exhibits
|
31.1 |
|
Certification of Chief Executive Officer pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. |
|
|
31.2 |
|
Certification of Chief Financial Officer pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. |
|
|
32.1 |
|
Certification of Chief Executive Officer pursuant to 18 U.S.C.
Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002. |
|
|
32.2 |
|
Certification of Chief Financial Officer pursuant to 18 U.S.C.
Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002. |
43
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this Report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
Date: May 2, 2008 |
|
COMMUNITY HEALTH SYSTEMS, INC. |
|
|
|
|
|
|
(Registrant) |
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Wayne T. Smith
Wayne T. Smith
|
|
|
|
|
|
|
Chairman of the Board,
President and Chief Executive Officer
(principal executive officer) |
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ W. Larry Cash
W. Larry Cash
|
|
|
|
|
|
|
Executive Vice President, Chief Financial
Officer and Director |
|
|
|
|
|
|
(principal financial officer) |
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ T. Mark Buford
T. Mark Buford
Vice President and Corporate Controller
|
|
|
|
|
|
|
(principal accounting officer) |
|
|
44
Index to Exhibits
|
|
|
No. |
|
Description |
31.1
|
|
Certification of Chief Executive Officer pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. |
|
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. |
|
|
|
32.1
|
|
Certification of Chief Executive Officer pursuant to 18 U.S.C.
Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002. |
|
|
|
32.2
|
|
Certification of Chief Financial Officer pursuant to 18 U.S.C.
Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002. |
45
Ex-31.1 Section 302 Certification of the CEO
Exhibit 31.1
I, Wayne T. Smith, certify that:
1. |
|
I have reviewed this quarterly report on Form 10-Q of Community Health Systems, Inc.; |
|
2. |
|
Based on my knowledge, this quarterly report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the
period covered by this quarterly report; |
|
3. |
|
Based on my knowledge, the financial statements, and other financial information included in
this quarterly report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented
in this quarterly report; |
|
4. |
|
The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and we have: |
|
|
|
a) designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this quarterly report
is being prepared; |
|
|
|
b) designed such internal controls over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles; |
|
|
|
c) evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
and |
|
|
|
d) disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants
fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial
reporting; and |
|
5. |
|
The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors: |
|
|
|
a) all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information; and |
|
|
|
b) any fraud, whether or not material, that involves management or other employees who have
a significant role in the registrants internal control over financial reporting. |
|
|
|
|
|
Date: May 2, 2008
|
|
/s/ Wayne T. Smith
Wayne T. Smith
Chairman of the Board, President
and Chief Executive Officer
|
|
|
46
Ex-31.2 Section 302 Certification of the CFO
Exhibit 31.2
I, W. Larry Cash, certify that:
1. |
|
I have reviewed this quarterly report on Form 10-Q of Community Health Systems, Inc.; |
|
2. |
|
Based on my knowledge, this quarterly report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the
period covered by this quarterly report; |
|
3. |
|
Based on my knowledge, the financial statements, and other financial information included in
this quarterly report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented
in this quarterly report; |
|
4. |
|
The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and we have: |
|
|
|
a) designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this quarterly report
is being prepared; |
|
|
|
b) designed such internal controls over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles; |
|
|
|
c) evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
and |
|
|
|
d) disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants
fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial
reporting; and |
|
5. |
|
The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors: |
|
|
|
a) all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information; and |
|
|
|
b) any fraud, whether or not material, that involves management or other employees who have
a significant role in the registrants internal control over financial reporting. |
|
|
|
|
|
Date: May 2, 2008
|
|
/s/ W. Larry Cash
|
|
|
|
|
W. Larry Cash
Executive Vice President, Chief
Financial Officer and Director |
|
|
47
Ex-32.1 Section 906 Certification of the CEO
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Community Health Systems, Inc. (the Company) on
Form 10-Q for the period ending March 31, 2008, as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, Wayne T. Smith, Chairman of the Board, President
and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and |
|
(2) |
|
The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company. |
|
|
|
/s/ Wayne T. Smith
Wayne T. Smith
|
|
|
Chairman of the Board, President and Chief Executive Officer |
May 2, 2008
A signed original of this written statement required by Section 906 has been provided to Community
Health Systems, Inc. and will be retained by Community Health Systems, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.
48
Ex-32.2 Section 906 Certification of the CFO
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Community Health Systems, Inc. (the Company) on
Form 10-Q for the period ending March 31, 2008, as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, W. Larry Cash, Executive Vice President, Chief
Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and |
|
(2) |
|
The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company. |
|
|
|
/s/ W. Larry Cash
W. Larry Cash
|
|
|
Executive Vice President, Chief Financial Officer and Director |
May 2, 2008
A signed original of this written statement required by Section 906 has been provided to Community
Health Systems, Inc. and will be retained by Community Health Systems, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.
49